WO2024064901A2 - Organisme de fermentation améliorée de production d'éthanol - Google Patents

Organisme de fermentation améliorée de production d'éthanol Download PDF

Info

Publication number
WO2024064901A2
WO2024064901A2 PCT/US2023/074919 US2023074919W WO2024064901A2 WO 2024064901 A2 WO2024064901 A2 WO 2024064901A2 US 2023074919 W US2023074919 W US 2023074919W WO 2024064901 A2 WO2024064901 A2 WO 2024064901A2
Authority
WO
WIPO (PCT)
Prior art keywords
saccharomyces cerevisiae
strain
nrrl
cerevisiae strain
yeast
Prior art date
Application number
PCT/US2023/074919
Other languages
English (en)
Other versions
WO2024064901A3 (fr
Inventor
Brianna Thompson
Philip John Livingstone Bell
Lauren Hehman
Christie STRAHLER
Guillermo Coward-Kelly
Robert Osborne
Hamid Yazdi
Dragana PURKOVIC
Kelly BOYD
Original Assignee
Novozymes A/S
Microbiogen Pty. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes A/S, Microbiogen Pty. Ltd. filed Critical Novozymes A/S
Publication of WO2024064901A2 publication Critical patent/WO2024064901A2/fr
Publication of WO2024064901A3 publication Critical patent/WO2024064901A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06—Ethanol, i.e. non-beverage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C12N1/185—Saccharomyces isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06—Ethanol, i.e. non-beverage
    • C12P7/08—Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate
    • C12P7/10—Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate substrate containing cellulosic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/85—Saccharomyces
    • C12R2001/865—Saccharomyces cerevisiae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01001—Alpha-amylase (3.2.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01003—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase

Definitions

  • the most commonly industrially used commercial process includes liquefying gelatinized starch at high temperature (about 85°C) using typically a bacterial alpha-amylase, followed by simultaneous saccharification and fermentation (SSF) carried out anaerobically in the presence of typically a glucoamylase and a Saccharomyces cerevisae yeast.
  • SSF simultaneous saccharification and fermentation
  • Yeast of the genus Saccharomyces exhibits many of the characteristics required for production of ethanol.
  • strains of Saccharomyces cerevisiae are widely used for the production of ethanol in the fuel ethanol industry.
  • Strains of Saccharomyces cerevisiae that are widely used in the fuel ethanol industry can produce high yields of ethanol under fermentation conditions found in, for example, the fermentation of corn mash.
  • An example of such a strain is the yeast used in commercially available ethanol yeast product called ETHANOL RED®.
  • Saccharomyces cerevisiae are used in the fuel ethanol industry to ferment sugars such as glucose, fructose, sucrose and maltose to produce ethanol via the glycolytic pathway.
  • sugars are obtained from sources such as corn and other grains, sugar juice, molasses, grape juice, fruit juices, and starchy root vegetables and may include the breakdown of cellulosic material into glucose.
  • Described herein are, inter alia, processes for producing ethanol from cellulosic- containing or starch-containing material and suitable yeasts for use in such processes.
  • a first aspect relates to a method of producing a fermentation product from a cellulosic- containing and/or starch-containing material, the method comprising:
  • step (b) fermenting the saccharified material of step (a) with a fermenting organism under suitable conditions to produce the fermentation product; wherein the fermenting organism is a strain of Saccharomyces cerevisiae deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no.
  • a fermenting organism is a strain of Saccharomyces cerevisiae deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no.
  • NRRL Y- 68199 (Saccharomyces cerevisiae strain MBG5225) or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227) or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307) or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase), NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318) or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glu
  • the method comprises recovering the fermentation product from the fermentation (e.g., by distillation).
  • fermentation and saccharification are performed simultaneously in a simultaneous saccharification and fermentation (SSF). In one embodiment, fermentation and saccharification are performed sequentially (SHF).
  • the fermentation product is ethanol.
  • step (a) comprises contacting the starch-containing and/or cellulosic-containing material with an enzyme composition.
  • step (a) comprises saccharifying a starch-containing material.
  • step (a) comprises i) liquefying a starch-containing material at a temperature above the initial gelatinization temperature using an alpha-amylase; and ii) saccharifying using a glucoamylase.
  • step (a) comprises saccharifying a cellulosic-containing material.
  • the cellulosic-containing material is pretreated.
  • the cellulosic-containing material comprises bagasse.
  • step (a) comprises contacting a cellulosic-containing material with an enzyme composition
  • the enzyme composition comprises one or more enzymes selected from a cellulase, an AA9 polypeptide, a hemicellulase, a Cl P, an esterase, an expansin, a ligninolytic enzyme, an oxidoreductase, a pectinase, a protease, and a swollenin.
  • the cellulase is one or more enzymes selected from an endoglucanase, a cellobiohydrolase, and a beta-glucosidase.
  • the hemicellulase is one or more enzymes selected a xylanase, an acetylxylan esterase, a feruloyl esterase, an arabinofuranosidase, a xylosidase, and a glucuronidase.
  • the method results in at least 0.25% (e.g., 0.5%, 0.75%, 1.0%, 1.25%, 1.5%, 1.75%, 2%, 3% or 5%) yield of fermentation product.
  • fermentation is conducted under low oxygen (e.g., anaerobic) conditions.
  • low oxygen e.g., anaerobic
  • the fermenting organism has one or more of the following properties: increased ethanol yield compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions; reduced acetaldehyde production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions; increased temperature tolerance compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No.
  • a second aspect relates to a Saccharomyces cerevisiae strain deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no. NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225) or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227) or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307) or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alphaamylase), NRRL Y-68202 (S
  • the strain has one or more of the following properties: increased ethanol yield compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions; reduced acetaldehyde production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions; increased temperature tolerance compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No.
  • a third aspect relates to a method of producing a derivative of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y- 68202 (Saccharomyces cerevisiae strain MBG5318), comprising: (a) culturing a first yeast strain with a second yeast strain, wherein the second yeast strain is NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y- 68202 (Saccharomyces cerevisiae strain MBG53
  • a fourth aspect relates to method of producing a derivative of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225) which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5225, NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227) which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5227, NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307) which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5307, or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318) which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5318, comprising: (a) providing: (i) a first yeast strain; and (ii) a second yeast strain, wherein the second yeast strain is NRRL Y-
  • step (c) comprises screening or selecting for a hybrid strain which exhibits one or more defining characteristic of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y- 68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318).
  • the method further comprises the step of: (d) repeating steps (a) and (b) with the screened or selected strain from step (c) as the first and/or second strain, until a derivative is obtained which exhibits the defining characteristics of NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318).
  • the culturing step (b) comprises: (i) sporulating the first yeast strain and the second yeast strain; (ii) hybridizing germinated spores produced by the first yeast strain with germinated spores produced by the second yeast strain.
  • a fifth aspect relates to method of producing a recombinant derivative of NRRL Y- 68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318), the method comprising: (a) transforming NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), NRRL Y-68201 (Saccharomyces cerevisiae strain MBG5307), or NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318) or a derivative thereof with one or more expression vectors (e.
  • a sixth aspect relates to Saccharomyces cerevisiae strain produced by any of the third, forth or fifth aspects.
  • a seventh aspect relates to method of producing ethanol, comprising incubating a Saccharomyces cerevisiae strain of the second or sixth aspect with a substrate comprising a fermentable sugar under conditions which permit fermentation of the fermentable sugar to produce ethanol.
  • An eighth aspect relates to composition comprising a Saccharomyces cerevisiae strain of any second or sixth aspects, and one or more naturally occurring and/or non-naturally occurring components.
  • the components are selected from the group consisting of: surfactants, emulsifiers, gums, swelling agents, and antioxidants.
  • Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5225 (deposited under Accession No. NRRL Y-68199 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA).
  • Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5227 (deposited under Accession No. NRRLY-68200 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA).
  • Saccharomyces cerevisiae strain is Saccharomyces cere visiae strain MBG5307 (deposited under Accession No. NRRLY-68201 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA).
  • Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5318 (deposited under Accession No. NRRLY-68202 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA).
  • Saccharomyces cerevisiae strain is in a viable form, in particular in dry, cream or compressed form.
  • Fig. 1 shows improved ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5225 compared to Ethanol Red® under non-stress conditions.
  • Fig. 2 shows lowered glycerol production from fermentation of Saccharomyces cerevisiae strain MBG5225 compared to Ethanol Red®.
  • Fig. 3 shows improved ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5227 compared to Ethanol Red® under non-stress conditions.
  • Fig. 4 shows lowered glycerol production from fermentation of Saccharomyces cerevisiae strain MBG5227 compared to Ethanol Red®.
  • Fig. 5 shows improved ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5318 compared to Ethanol Red® under non-stress conditions.
  • Fig. 6 shows lowered glycerol production from fermentation of Saccharomyces cerevisiae strain MBG5318 compared to Ethanol Red®.
  • Fig. 7 shows improved ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5307 compared to Ethanol Red® under non-stress conditions.
  • Fig. 8 shows lowered glycerol production from fermentation of Saccharomyces cerevisiae strain MBG5307 compared to Ethanol Red®.
  • Fig. 9 shows improved ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5225 compared to Ethanol Red® under temperature and organic stress conditions.
  • Fig. 10 shows improved ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5227 compared to Ethanol Red® under temperature and organic stress conditions.
  • Fig. 11 shows improved ethanol yield from fermentation of Saccharomyces cerevisiae strain MBG5318 compared to Ethanol Red® under temperature and organic stress conditions.
  • allelic variant means any of two or more alternative forms of a gene occupying the same chromosomal locus. Allelic variation arises naturally through mutation, and may result in polymorphism within populations. Gene mutations can be silent (no change in the encoded polypeptide) or may encode polypeptides having altered amino acid sequences.
  • An allelic variant of a polypeptide is a polypeptide encoded by an allelic variant of a gene.
  • Alpha-amylase means an 1 ,4-alpha-D-glucan glucanohydrolase, EC. 3.2.1.1 , which catalyze hydrolysis of starch and other linear and branched 1 ,4-glucosidic oligo- and polysaccharides. Alpha-amylase activity can be determined using methods known in the art (e.g., using an alpha amylase assay described W02020/023411).
  • Auxiliary Activity 9 The term “Auxiliary Activity 9” or “AA9” means a polypeptide classified as a lytic polysaccharide monooxygenase (Quinlan et al., 2011 , Proc. Natl. Acad.
  • AA9 polypeptides were formerly classified into the glycoside hydrolase Family 61 (GH61) according to Henrissat, 1991 , Biochem. J. 280: 309-316, and Henrissat and Bairoch, 1996, Biochem. J. 316: 695-696.
  • AA9 polypeptides enhance the hydrolysis of a cellulosic-containing material by an enzyme having cellulolytic activity.
  • Cellulolytic enhancing activity can be determined by measuring the increase in reducing sugars or the increase of the total of cellobiose and glucose from the hydrolysis of a cellulosic-containing material by cellulolytic enzyme under the following conditions: 1-50 mg of total protein/g of cellulose in pretreated corn stover (PCS), wherein total protein is comprised of 50-99.5% w/w cellulolytic enzyme protein and 0.5-50% w/w protein of an AA9 polypeptide for 1-7 days at a suitable temperature, such as 40C-80°C, e.g., 50°C, 55°C, 60°C, 65°C, or 70°C, and a suitable pH, such as 4-9, e.g., 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, or 8.5, compared to a control hydrolysis
  • AA9 polypeptide enhancing activity can be determined using a mixture of CELLUCLAST® 1.5L (Novozymes A/S, Bagsvaerd, Denmark) and beta-glucosidase as the source of the cellulolytic activity, wherein the beta-glucosidase is present at a weight of at least 2-5% protein of the cellulase protein loading.
  • the beta-glucosidase is an Aspergillus oryzae beta-glucosidase (e.g., recombinantly produced in Aspergillus oryzae according to WQ02/095014).
  • the beta-glucosidase is an Aspergillus fumigatus beta-glucosidase (e.g., recombinantly produced in Aspergillus oryzae as described in WQ02/095014).
  • AA9 polypeptide enhancing activity can also be determined by incubating an AA9 polypeptide with 0.5% phosphoric acid swollen cellulose (PASC), 100 mM sodium acetate pH 5, 1 mM MnSO4, 0.1 % gallic acid, 0.025 mg/ml of Aspergillus fumigatus beta-glucosidase, and 0.01% TRITON® X-100 (4-(1, 1 ,3,3-tetramethylbutyl)phenyl-polyethylene glycol) for 24-96 hours at 40°C followed by determination of the glucose released from the PASC.
  • PASC phosphoric acid swollen cellulose
  • TRITON® X-100 4-(1, 1 ,3,3-tetramethylbutyl)phenyl-polyethylene glycol
  • AA9 polypeptide enhancing activity can also be determined according to WO2013/028928 for high temperature compositions.
  • AA9 polypeptides enhance the hydrolysis of a cellulosic-containing material catalyzed by enzyme having cellulolytic activity by reducing the amount of cellulolytic enzyme required to reach the same degree of hydrolysis preferably at least 1.01-fold, e.g., at least 1.05-fold, at least 1.10-fold, at least 1.25-fold, at least 1.5-fold, at least 2-fold, at least 3-fold, at least 4-fold, at least 5-fold, at least 10-fold, or at least 20-fold.
  • Beta-glucosidase means a beta-D-glucoside glucohydrolase (E.C.
  • Beta-glucosidase activity can be determined using p-nitrophenyl-beta-D-glucopyranoside as substrate according to the procedure of Venturi et al., 2002, J. Basic Microbiol. 42: 55-66.
  • One unit of beta-glucosidase is defined as 1.0 pmole of p-nitrophenolate anion produced per minute at 25°C, pH 4.8 from 1 mM p-nitrophenyl-beta-D-glucopyranoside as substrate in 50 mM sodium citrate containing 0.01% TWEEN® 20.
  • Beta-xylosidase means a beta-D-xyloside xylohydrolase (E.C. 3.2.1.37) that catalyzes the exo-hydrolysis of short beta (1 ⁇ 4)-xylooligosaccharides to remove successive D-xylose residues from non-reducing termini.
  • Beta-xylosidase activity can be determined using 1 mM p-nitrophenyl-beta-D-xyloside as substrate in 100 mM sodium citrate containing 0.01% TWEEN® 20 at pH 5, 40°C.
  • beta-xylosidase is defined as 1.0 pmole of p-nitrophenolate anion produced per minute at 40°C, pH 5 from 1 mM p- nitrophenyl-beta-D-xyloside in 100 mM sodium citrate containing 0.01 % TWEEN® 20.
  • Catalase means a hydrogen-peroxide:hydrogen-peroxide oxidoreductase (EC 1.11.1.6) that catalyzes the conversion of 2 H2O2 to O2 + 2 H2O.
  • catalase activity is determined according to U.S. Patent No. 5,646,025.
  • One unit of catalase activity equals the amount of enzyme that catalyzes the oxidation of 1 pmole of hydrogen peroxide under the assay conditions.
  • Cellobiohydrolase means a 1 ,4-beta-D-glucan cellobiohydrolase (E.C. 3.2.1.91 and E.C. 3.2.1.176) that catalyzes the hydrolysis of 1 ,4-beta- D-glucosidic linkages in cellulose, cellooligosaccharides, or any beta-1 ,4-linked glucose containing polymer, releasing cellobiose from the reducing end (cellobiohydrolase I) or nonreducing end (cellobiohydrolase II) of the chain (Teeri, 1997, Trends in Biotechnology 15: 160- 167; Teeri et al., 1998, Biochem. Soc. Trans.
  • E.C. 3.2.1.91 and E.C. 3.2.1.176 catalyzes the hydrolysis of 1 ,4-beta- D-glucosidic linkages in cellulose, cellooligosaccharides, or any beta-1 ,4-linked glucose containing polymer,
  • Cellobiohydrolase activity can be determined according to the procedures described by Lever et al., 1972, Anal. Biochem. 47: 273-279; van Tilbeurgh et al., 1982, FEBS Letters 149: 152-156; van Tilbeurgh and Claeyssens, 1985, FEBS Letters 187: 283-288; and Tomme et al., 1988, Eur. J. Biochem. 170: 575-581.
  • Cellulolytic enzyme or cellulase means one or more (e.g., several) enzymes that hydrolyze a cellulosic-containing material. Such enzymes include endoglucanase(s), cellobiohydrolase(s), beta-glucosidase(s), or combinations thereof.
  • the two basic approaches for measuring cellulolytic enzyme activity include: (1) measuring the total cellulolytic enzyme activity, and (2) measuring the individual cellulolytic enzyme activities (endoglucanases, cellobiohydrolases, and beta-glucosidases) as reviewed in Zhang et al., 2006, Biotechnology Advances 24: 452-481.
  • Total cellulolytic enzyme activity can be measured using insoluble substrates, including Whatman N°1 filter paper, microcrystalline cellulose, bacterial cellulose, algal cellulose, cotton, pretreated lignocellulose, etc.
  • the most common total cellulolytic activity assay is the filter paper assay using Whatman N°1 filter paper as the substrate.
  • the assay was established by the International Union of Pure and Applied Chemistry (IUPAC) (Ghose, 1987, Pure Appl. Chem. 59: 257-68).
  • Cellulolytic enzyme activity can be determined by measuring the increase in production/release of sugars during hydrolysis of a cellulosic-containing material by cellulolytic enzyme(s) under the following conditions: 1-50 mg of cellulolytic enzyme protein/g of cellulose in pretreated corn stover (PCS) (or other pretreated cellulosic-containing material) for 3-7 days at a suitable temperature such as 40°C-80°C, e.g., 50°C, 55°C, 60°C, 65°C, or 70°C, and a suitable pH such as 4-9, e.g., 5.0, 5.5, 6.0, 6.5, or 7.0, compared to a control hydrolysis without addition of cellulolytic enzyme protein.
  • PCS pretreated corn stover
  • Typical conditions are 1 ml reactions, washed or unwashed PCS, 5% insoluble solids (dry weight), 50 mM sodium acetate pH 5, 1 mM MnSC , 50°C, 55°C, or 60°C, 72 hours, sugar analysis by AMINEX® HPX-87H column chromatography (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
  • Coding sequence means a polynucleotide sequence, which specifies the amino acid sequence of a polypeptide.
  • the boundaries of the coding sequence are generally determined by an open reading frame, which usually begins with the ATG start codon or alternative start codons such as GTG and TTG and ends with a stop codon such as TAA, TAG, and TGA.
  • the coding sequence may be a sequence of genomic DNA, cDNA, a synthetic polynucleotide, and/or a recombinant polynucleotide.
  • Endoglucanase means a 4-(1 ,3;1 ,4)-beta-D-glucan 4- glucanohydrolase (E.C. 3.2.1.4) that catalyzes endohydrolysis of 1 ,4-beta-D-glycosidic linkages in cellulose, cellulose derivatives (such as carboxymethyl cellulose and hydroxyethyl cellulose), lichenin, beta-1 ,4 bonds in mixed beta-1 ,3-1 ,4 glucans such as cereal beta-D- glucans or xyloglucans, and other plant material containing cellulosic components.
  • Endoglucanase activity can be determined by measuring reduction in substrate viscosity or increase in reducing ends determined by a reducing sugar assay (Zhang et al., 2006, Biotechnology Advances 24: 452-481). Endoglucanase activity can also be determined using carboxymethyl cellulose (CMC) as substrate according to the procedure of Ghose, 1987, Pure and Appl. Chem. 59: 257-268, at pH 5, 40°C.
  • CMC carboxymethyl cellulose
  • expression includes any step involved in the production of the polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion. Expression can be measured — for example, to detect increased expression — by techniques known in the art, such as measuring levels of mRNA and/or translated polypeptide.
  • Expression vector means a linear or circular DNA molecule that comprises a polynucleotide encoding a polypeptide and is operably linked to control sequences that provide for its expression.
  • Fermentable medium refers to a medium comprising one or more (e.g., two, several) sugars, such as glucose, fructose, sucrose, cellobiose, xylose, xylulose, arabinose, mannose, galactose, and/or soluble oligosaccharides, wherein the medium is capable, in part, of being converted (fermented) by a host cell into a desired product, such as ethanol.
  • the fermentation medium is derived from a natural source, such as sugar cane, starch, or cellulose, and may be the result of pretreating the source by enzymatic hydrolysis (saccharification).
  • fermentation medium is understood herein to refer to a medium before the fermenting organism is added, such as, a medium resulting from a saccharification process, as well as a medium used in a simultaneous saccharification and fermentation process (SSF).
  • Glucoamylase (1 ,4-alpha-D-glucan glucohydrolase, EC 3.2.1.3) is defined as an enzyme that catalyzes the release of D-glucose from the nonreducing ends of starch or related oligo- and polysaccharide molecules.
  • glucoamylase activity may be determined according to the procedures known in the art, such as those described in W02020/023411.
  • Hemicellulolytic enzyme or hemicellulase means one or more (e.g., several) enzymes that hydrolyze a hemicellulosic material. See, for example, Shallom and Shoham, 2003, Current Opinion In Microbiology 6(3): 219-228). Hemicellulases are key components in the degradation of plant biomass.
  • hemicellulases include, but are not limited to, an acetylmannan esterase, an acetylxylan esterase, an arabinanase, an arabinofuranosidase, a coumaric acid esterase, a feruloyl esterase, a galactosidase, a glucuronidase, a glucuronoyl esterase, a mannanase, a mannosidase, a xylanase, and a xylosidase.
  • hemicelluloses are a heterogeneous group of branched and linear polysaccharides that are bound via hydrogen bonds to the cellulose microfibrils in the plant cell wall, crosslinking them into a robust network. Hemicelluloses are also covalently attached to lignin, forming together with cellulose a highly complex structure. The variable structure and organization of hemicelluloses require the concerted action of many enzymes for its complete degradation.
  • the catalytic modules of hemicellulases are either glycoside hydrolases (GHs) that hydrolyze glycosidic bonds, or carbohydrate esterases (CEs), which hydrolyze ester linkages of acetate or ferulic acid side groups.
  • GHs glycoside hydrolases
  • CEs carbohydrate esterases
  • catalytic modules based on homology of their primary sequence, can be assigned into GH and CE families. Some families, with an overall similar fold, can be further grouped into clans, marked alphabetically (e.g., GH-A). A most informative and updated classification of these and other carbohydrate active enzymes is available in the Carbohydrate-Active Enzymes (CAZy) database. Hemicellulolytic enzyme activities can be measured according to Ghose and Bisaria, 1987, Pure & Appl. Chem.
  • 59: 1739-1752 at a suitable temperature such as 40°C-80°C, e.g., 50°C, 55°C, 60°C, 65°C, or 70°C, and a suitable pH such as 4-9, e.g., 5.0, 5.5, 6.0, 6.5, or 7.0.
  • a suitable temperature such as 40°C-80°C, e.g., 50°C, 55°C, 60°C, 65°C, or 70°C
  • a suitable pH such as 4-9, e.g., 5.0, 5.5, 6.0, 6.5, or 7.0.
  • Heterologous polynucleotide is defined herein as a polynucleotide that is not native to the host cell; a native polynucleotide in which structural modifications have been made to the coding region; a native polynucleotide whose expression is quantitatively altered as a result of a manipulation of the DNA by recombinant DNA techniques, e.g., a different (foreign) promoter; or a native polynucleotide in a host cell having one or more extra copies of the polynucleotide to quantitatively alter expression.
  • a “heterologous gene” is a gene comprising a heterologous polynucleotide.
  • Mature polypeptide is defined herein as a polypeptide having biological activity that is in its final form following translation and any post-translational modifications, such as N-terminal processing, C-terminal truncation, glycosylation, phosphorylation, etc.
  • the mature polypeptide sequence lacks a signal sequence, which may be determined using techniques known in the art (See, e.g., Zhang and Henzel, 2004, Protein Science 13: 2819-2824).
  • the term “mature polypeptide coding sequence” means a polynucleotide that encodes a mature polypeptide.
  • Pentose means a five-carbon monosaccharide (e.g., xylose, arabinose, ribose, lyxose, ribulose, and xylulose). Pentoses, such as D-xylose and L- arabinose, may be derived, e.g., through saccharification of a plant cell wall polysaccharide.
  • Pretreated corn stover The term “Pretreated Corn Stover” or “PCS” means a cellulosic-containing material derived from corn stover by treatment with heat and dilute sulfuric acid, alkaline pretreatment, neutral pretreatment, or any pretreatment known in the art.
  • Protease is defined herein as an enzyme that hydrolyses peptide bonds. It includes any enzyme belonging to the EC 3.4 enzyme group (including each of the thirteen subclasses thereof).
  • the EC number refers to Enzyme Nomenclature 1992 from NC- ILIBMB, Academic Press, San Diego, California, including supplements 1-5 published in Eur. J. Biochem. 223: 1-5 (1994); Eur. J. Biochem. 232: 1-6 (1995); Eur J. Biochem. 237: 1-5 (1996); Eur J. Biochem. 250: 1-6 (1997); and Eur. J. Biochem. 264: 610-650 (1999); respectively.
  • subtilases refer to a sub-group of serine protease according to Siezen et al., 1991 , Protein Engng. 4: 719-737 and Siezen et al., 1997, Protein Science 6: 501-523.
  • Serine proteases or serine peptidases is a subgroup of proteases characterised by having a serine in the active site, which forms a covalent adduct with the substrate.
  • the subtilases (and the serine proteases) are characterised by having two active site amino acid residues apart from the serine, namely a histidine and an aspartic acid residue.
  • the subtilases may be divided into 6 sub-divisions, i.e.
  • proteolytic activity means a proteolytic activity (EC 3.4). Protease activity may be determined using methods described in the art (e.g., US 2015/0125925) or using commercially available assay kits (e.g., Sigma-Aldrich).
  • Pullulanase means a starch debranching enzyme having pullulan 6-glucano-hydrolase activity (EC 3.2.1.41) that catalyzes the hydrolysis the a- 1 ,6- glycosidic bonds in pullulan, releasing maltotriose with reducing carbohydrate ends.
  • pullulanase activity can be determined according to a PHADEBAS assay or the sweet potato starch assay described in WO2016/087237.
  • Sequence Identity The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter “sequence identity”.
  • the degree of sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, J. Mol. Biol. 1970, 48, 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et aL, Trends Genet 2000, 16, 27Q-277), preferably version 3.0.0 or later.
  • the optional parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix.
  • the output of Needle labeled “longest identity” (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:
  • the degree of sequence identity between two deoxyribonucleotide sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, supra) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et aL, 2000, supra), preferably version 3.0.0 or later.
  • the optional parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EDNAFULL (EMBOSS version of NCBI NUC4.4) substitution matrix.
  • the output of Needle labeled “longest identity” (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:
  • xylanase means a 1 ,4-beta-D-xylan-xylohydrolase (E.C. 3.2.1.8) that catalyzes the endohydrolysis of 1 ,4-beta-D-xylosidic linkages in xylans.
  • Xylanase activity can be determined with 0.2% AZCL-arabinoxylan as substrate in 0.01% TRITON® X-100 and 200 mM sodium phosphate pH 6 at 37°C.
  • One unit of xylanase activity is defined as 1 .0 pmole of azurine produced per minute at 37°C, pH 6 from 0.2% AZCL-arabinoxylan as substrate in 200 mM sodium phosphate pH 6.
  • Xylitol dehydrogenase The term “xylitol dehydrogenase” or “XDH” (AKA D-xylulose reductase) is classified as E.C. 1.1.1.9 and means an enzyme that catalyzes the conversion of xylitol to D-xylulose. Xylitol dehydrogenase activity can be determined using methods known in the art (e.g., Richard et al., 1999, FEBS Letters 457, 135-138).
  • Xylose isomerase The term “xylose isomerase” or “XI” means an enzyme which can catalyze D-xylose into D-xylulose in vivo, and convert D-glucose into D-fructose in vitro. Xylose isomerase is also known as “glucose isomerase” and is classified as E.C. 5.3.1.5. As the structure of the enzyme is very stable, the xylose isomerase is a good model for studying the relationships between protein structure and functions (Karimaki et al., Protein Eng Des Sei, 12004, 17 (12):861-869).
  • Xylose Isomerase activity may be determined using techniques known in the art (e.g., a coupled enzyme assay using D-sorbitol dehygrogenase, as described by Verhoeven et. al., 2017, Sci Rep 7, 46155).
  • Xylulokinase The term “xylulokinase” or “XK” is classified as E.C. 2.7.1.17 and means an enzyme that catalyzes the conversion of D-xylulose to D-xylulose 5-phosphate. Xylulokinase activity can be determined using methods known in the art (e.g., Richard et al., 2000, FEBS Microbiol. Letters 190, 39-43)
  • references to “about” a value or parameter herein includes embodiments that are directed to that value or parameter per se.
  • description referring to “about X” includes the embodiment “X”.
  • “about” includes a range that encompasses at least the uncertainty associated with the method of measuring the particular value, and can include a range of plus or minus two standard deviations around the stated value.
  • reference to a gene or polypeptide that is “derived from” another gene or polypeptide X includes the gene or polypeptide X.
  • a fermentation product such as ethanol
  • the Applicant has created new Saccharomyces cerevisiae strains having improved ethanol titres, increased temperature tolerance, increased sugar consumption, high ethanol to glycerol ratios, and reduced by-products to maximize product yield.
  • a method of producing a fermentation product from a cellulosic- containing or starch-containing material comprising:
  • step (b) fermenting the saccharified material of step (a) with a fermenting organism described herein.
  • Steps a) and b) may be carried out either sequentially or simultaneously (SSF). In one embodiment, steps a) and b) are carried out simultaneously (SSF). In another embodiment, steps a) and b) are carried out sequentially.
  • the fermenting organism is a Saccharomyces cerevisiae strain deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no. NRRL Y-68199 (Saccharomyces cerevisiae strain MBG5225), or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase) or a fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae MBG5225.
  • NRRL Agricultural Research Service Patent Culture Collection
  • the fermenting organism is a Saccharomyces cerevisiae strain deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no. NRRL Y-68200 (Saccharomyces cerevisiae strain MBG5227), or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase) or a fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae MBG5227.
  • NRRL Agricultural Research Service Patent Culture Collection
  • the fermenting organism is a Saccharomyces cerevisiae strain deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no. Y-68201 (Saccharomyces cerevisiae strain MBG5307), or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase) or a fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae MBG5307.
  • NRRL Agricultural Research Service Patent Culture Collection
  • the fermenting organism is a Saccharomyces cerevisiae strain deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no. NRRL Y-68202 (Saccharomyces cerevisiae strain MBG5318), or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase) or a fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae MBG5318.
  • NRRL Agricultural Research Service Patent Culture Collection
  • the fermenting organism has one or more of the following properties: reduced acetaldehyde production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions; increased temperature tolerance compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions; reduced maltose (DP2) production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No.
  • DP2 reduced maltose
  • the fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 provides an ethanol yield boost over Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) of more than 1.0%, e.g., more than 2.0%, such as more than 2.5%, such as about 2.9% using the same process set-up and conditions, e.g., conditions described herein.
  • the fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 reduces acetaldehyde production more than 10%, e.g., more than 20%, more than 30%, more than 40%, more than 45%, such as between 5-60%, such as 30-50%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions, e.g., conditions described herein.
  • the fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 increases the temperature tolerance compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions, e.g., conditions described herein.
  • Increased temperature tolerance is an advantage as the fermentation temperature may fluctuate to some degree.
  • the temperature may therefore increase naturally from the yeast’s metabolism.
  • the plant may use heat exchangers to control early fermentation temperatures so it does not go too high.
  • the peak temperature is typically about 34°C.
  • the cooling water used in heat exchangers is not cold enough to control the temperatures. Therefore, in plants that do not have chillers (i.e. , a water refrigeration system), the early fermentation temperatures can reach above 36.5°C which stresses the yeast.
  • the fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 reduces maltose (DP2) production by more than 3%, e.g., more than 4%, more than 5%, more than 6%, more than 7%, such as between 2-15%, such as 5-10%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions, e.g., conditions described herein.
  • DP2 maltose
  • the fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 reduces glycerol production by more than 3%, e.g., more than 4%, more than 5%, more than 6%, more than 7%, such as between 2-15%, such as 5-10%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions, e.g., conditions described herein.
  • the fermenting organism may also be a derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318.
  • a “derivative” of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 is a strain derived from said strain, such as through mutagenesis, recombinant DNA technology, mating, cell fusion, or cytoduction between yeast strains.
  • the strain derived from Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 may be a direct progeny (i.e.
  • a derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 is a hybrid strain produced by culturing a first yeast strain with Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 under conditions which permit combining of DNA between the first yeast strain and Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318.
  • the derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318.
  • Derivatives of Saccharomyces which exhibit one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 are produced using Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, respectively.
  • Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 forms the basis for preparing other strains having the defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318.
  • strains of Saccharomyces which exhibit one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 can be derived from Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, respectively, using methods such as classical mating, cell fusion, or cytoduction between yeast strains, mutagenesis or recombinant DNA technology.
  • a derivative of Saccharomyces cerevisiae strain MBG5225 exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225 may be produced by:
  • step (c) optionally repeating steps (a) and (b) with the screened or selected strain as the first yeast strain and/or the second yeast strain, until a derivative of Saccharomyces cerevisiae strain MBG5225 is obtained which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225.
  • a derivative of Saccharomyces cerevisiae strain MBG5227 exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227 may be produced by:
  • step (c) optionally repeating steps (a) and (b) with the screened or selected strain as the first yeast strain and/or the second yeast strain, until a derivative of Saccharomyces cerevisiae strain MBG5227 is obtained which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227.
  • a derivative of Saccharomyces cerevisiae strain MBG5307 exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307 may be produced by:
  • step (c) optionally repeating steps (a) and (b) with the screened or selected strain as the first yeast strain and/or the second yeast strain, until a derivative of Saccharomyces cerevisiae strain MBG5307 is obtained which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307.
  • a derivative of Saccharomyces cerevisiae strain MBG5318 exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318 may be produced by:
  • the first yeast strain may be any strain of yeast if the DNA of the strain can be combined with the second yeast strain using methods such as classical mating, cell fusion or cytoduction.
  • the first yeast strain is a Saccharomyces strain. More typically, the first yeast strain is a Saccharomyces cerevisiae strain.
  • Saccharomyces cerevisiae is as defined by Kurtzman (2003) FEMS Yeast Research vol 4 pp. 233-245.
  • the first yeast strain may have desired properties which are sought to be combined with the defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318.
  • the first yeast strain may be, for example, any Saccharomyces cerevisiae strain, such as for example ETHANOL RED®.
  • the first yeast strain may be Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318).
  • the first and second yeast strains are cultured under conditions which permit combining of DNA between the yeast strains.
  • “combining of DNA” between yeast strains refers to combining of all or a part of the genome of the yeast strains.
  • Combining of DNA between yeast strains may be by any method suitable for combining DNA of at least two yeast cells, and may include, for example, mating methods which comprise sporulation of the yeast strains to produce haploid cells and subsequent hybridising of compatible haploid cells; cytoduction; or cell fusion such as protoplast fusion.
  • culturing the first yeast strain with the second yeast, under conditions which permit combining of DNA between the first yeast strain and the second yeast strain comprises:
  • the method of producing a derivative of Saccharomyces cerevisiae strain MBG5225 which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225 comprises:
  • step (d) screening or selecting for a derivative of Saccharomyces cerevisiae strain MBG5225, such as screening or selecting for a derivative with increased ethanol production compared to the first strain, and/or higher ethanol yield from glucose during fermentation of corn mash than the first strain; (e) optionally repeating steps (b) to (d) with the screened or selected strain as the first and/or second yeast strain.
  • the method of producing a derivative of Saccharomyces cerevisiae strain MBG5227 which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227 comprises:
  • step (e) optionally repeating steps (b) to (d) with the screened or selected strain as the first and/or second yeast strain.
  • the method of producing a derivative of Saccharomyces cerevisiae strain MBG5307 which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307 comprises:
  • step (e) optionally repeating steps (b) to (d) with the screened or selected strain as the first and/or second yeast strain.
  • the method of producing a derivative of Saccharomyces cerevisiae strain MBG5318 which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318 comprises: (a) providing: (i) a first yeast strain; and (ii) a second yeast strain, wherein the second yeast strain is Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318);
  • step (e) optionally repeating steps (b) to (d) with the screened or selected strain as the first and/or second yeast strain.
  • the yeast strains may be cultured under conditions which permit cell fusion.
  • Methods for the generation of intraspecific or interspecific hybrids using cell fusion techniques are described in, for example, Spencer et al. (1990) in, Yeast Technology, Spencer JFT and Spencer DM (Eds), Springer Verlag, New York.
  • the yeast strains may be cultured under conditions which permit cytoduction.
  • Methods for cytoduction are described in, for example, Inge-Vechymov et al. (1986) Genetika 22: 2625-2636; Johnston (1990) in, Yeast technology, Spencer JFT and Spencer DM (Eds), Springer Verlag, New York.
  • screening or selecting for derivatives of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 comprises screening or selecting for a derivative with increased ethanol production compared to the first strain, and/or screening or selecting for a hybrid which has a higher ethanol yield, e.g., as described in WO2019/161227.
  • a derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, respectively, may be a mutant of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318.
  • Methods for producing mutants of Saccharomyces yeast, and specifically mutants of Saccharomyces cerevisiae are known in the art and described in, for example, Lawrence C.W. (1991) Methods in Enzymology, 194: 273-281.
  • a derivative of Saccharomyces cerevisiae strain MBG5225 which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225 may be a recombinant derivative of Saccharomyces cerevisiae strain MBG5225.
  • a derivative of Saccharomyces cerevisiae strain MBG5227 which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227 may be a recombinant derivative of Saccharomyces cerevisiae strain MBG5227.
  • a derivative of Saccharomyces cerevisiae strain MBG5307 which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307 may be a recombinant derivative of Saccharomyces cerevisiae strain MBG5307.
  • a derivative of Saccharomyces cerevisiae strain MBG5318 which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318 may be a recombinant derivative of Saccharomyces cerevisiae strain MBG5318.
  • a recombinant derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 is a strain produced by introducing into Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 a nucleic acid using recombinant DNA technology.
  • Recombinant methods for the introduction of nucleic acid into Saccharomyces yeast cells, and in particular strains of Saccharomyces are known in the art and are described in, for example, Ausubel, F. M. et al. (1997), Current Protocols in Molecular Biology, Volume 2, pages 13.7.1 to 13.7.7, published by John Wiley & Sons Inc.
  • a recombinant derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 has been prepared by genetically modifying the strain (or another derivative thereof) to express a heterologous enzyme, such as an alphaamylase and/or glucoamylase described herein (or any enzyme described in W02020/023411 , the content of which is incorporated herein by reference).
  • a heterologous enzyme such as an alphaamylase and/or glucoamylase described herein (or any enzyme described in W02020/023411 , the content of which is incorporated herein by reference).
  • a method of producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5225 (deposited under Accession No. NRRL Y-68199 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA) comprising:
  • Saccharomyces cerevisiae strain MBG5225 (or a derivative of Saccharomyces cerevisiae strain MBG5225) with one or more expression vectors encoding a heterologous enzymes, such as a glucoamylase and/or an alpha-amylase; and
  • a derivative of Saccharomyces cerevisiae strain MBG5225 may be prepared by:
  • step (c) optionally repeating steps (a) and (b) using a hybrid strain isolated in step (b) as the first yeast strain and/or the derivative of Saccharomyces cerevisiae strain MBG5225.
  • a method of producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5227 (deposited under Accession No. NRRL Y-68200 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA) comprising:
  • Saccharomyces cerevisiae strain MBG5227 (or a derivative of Saccharomyces cerevisiae strain MBG5227) with one or more expression vectors encoding a heterologous enzyme, such as a glucoamylase and/or an alpha-amylase; and
  • a derivative of Saccharomyces cerevisiae strain MBG5227 may be prepared by:
  • step (c) optionally repeating steps (a) and (b) using a hybrid strain isolated in step (b) as the first yeast strain and/or the derivative of Saccharomyces cerevisiae strain MBG5227.
  • a method of producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5307 (deposited under Accession No. NRRL Y-68201 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA) comprising:
  • a derivative of Saccharomyces cerevisiae strain MBG5307 may be prepared by:
  • step (b) isolating hybrid strains; and (c) optionally repeating steps (a) and (b) using a hybrid strain isolated in step (b) as the first yeast strain and/or the derivative of Saccharomyces cerevisiae strain MBG5307.
  • a method of producing a recombinant derivative of Saccharomyces cerevisiae strain MBG5318 (deposited under Accession No. NRRL Y-68202 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA) comprising:
  • Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318) with one or more expression vectors encoding a heterologous enzyme, such as a glucoamylase and/or an alpha-amylase; and
  • a derivative of Saccharomyces cerevisiae strain MBG5318 may be prepared by:
  • step (c) optionally repeating steps (a) and (b) using a hybrid strain isolated in step (b) as the first yeast strain and/or the derivative of Saccharomyces cerevisiae strain MBG5318.
  • the derivative of Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318 expresses a glucoamylase and/or an alpha-amylase.
  • the derivatives expressing glucoamylase and/or alpha-amylase have been generated in order to improve ethanol yield and to improve process economy by cutting enzyme costs since part or all of the necessary enzymes needed to hydrolyse starch will be produced by the yeast organism.
  • This aspect relates to a formulated Saccharomyces yeast composition
  • a yeast strain described herein and a naturally occurring and/or a nonenaturally occurring component.
  • composition comprising Saccharomyces cerevisiae strain MBG5225 (or a derivative of Saccharomyces cerevisiae strain MBG5225), Saccharomyces cerevisiae strain MBG5227 (or a derivative of Saccharomyces cerevisiae strain MBG5227), Saccharomyces cerevisiae strain MBG5307 (or a derivative of Saccharomyces cerevisiae strain MBG5307), or Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318).
  • the composition may be, for example, cream yeast, compressed yeast, wet yeast, dry yeast, semi-dried yeast, crumble yeast, stabilized liquid yeast or frozen yeast. Methods for preparing such yeast compositions are known in the art.
  • the Saccharomyces cerevisiae yeast strain is dry yeast, such as active dry yeast or instant yeast. In one embodiment, the Saccharomyces cerevisiae yeast strain is crumbled yeast. In one embodiment, the Saccharomyces cerevisiae yeast strain is compressed yeast. In one embodiment, the Saccharomyces cerevisiae yeast strain is acream yeast.
  • composition comprising a Saccharomyces yeast described herein, in particular Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and one or more of the component selected from the group consisting of: surfactants, emulsifiers, gums, swelling agent, and antioxidants and other processing aids.
  • compositions described herein may comprise a Saccharomyces yeast described herein, in particular Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable surfactants.
  • the surfactant(s) is/are an anionic surfactant, cationic surfactant, and/or nonionic surfactant.
  • compositions described herein may comprise a Saccharomyces yeast described herein, in particular Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable emulsifier.
  • the emulsifier is a fatty-acid ester of sorbitan.
  • the emulsifier is selected from the group of sorbitan monostearate (SMS), citric acid esters of monodiglycerides, polyglycerolester, fatty acid esters of propylene glycol.
  • the composition comprises a Saccharomyces yeast described herein, in particular Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and Olindronal SMS, Olindronal SK, or Olindronal SPL including composition concerned in European Patent No. 1 ,724,336 (hereby incorporated by reference). These products are commercially available from Bussetti, Austria, for active dry yeast.
  • compositions described herein may comprise a Saccharomyces yeast described herein, in particular Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable gum.
  • the gum is selected from the group of carob, guar, tragacanth, arabic, xanthan and acacia gum, in particular for cream, compressed and dry yeast.
  • compositions described herein may comprise a Saccharomyces yeast described herein, in particular Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable swelling agent.
  • the swelling agent is methyl cellulose or carboxymethyl cellulose.
  • compositions described herein may comprise a Saccharomyces yeast described herein, in particular Saccharomyces cerevisiae strain MBG5225, MBG5227, MBG5307, or MBG5318, and any suitable anti-oxidant.
  • the antioxidant is butylated hydroxyanisol (BHA) and/or butylated hydroxytoluene (BHT), or ascorbic acid (vitamin C), particular for active dry yeast.
  • the methods described herein produce a fermentation product from a starch-containing material.
  • Starch-containing material is well-known in the art, containing two types of homopolysaccharides (amylose and amylopectin) and is linked by alpha-(1-4)-D-glycosidic bonds. Any suitable starch-containing starting material may be used. The starting material is generally selected based on the desired fermentation product, such as ethanol. Examples of starch-containing starting materials include cereal, tubers or grains.
  • the starch-containing material may be corn, wheat, barley, rye, milo, sago, cassava, tapioca, sorghum, oat, rice, peas, beans, or sweet potatoes, or mixtures thereof. Contemplated are also waxy and non-waxy types of corn and barley.
  • the starch-containing starting material is corn. In one embodiment, the starch-containing starting material is wheat. In one embodiment, the starch-containing starting material is barley. In one embodiment, the starch-containing starting material is rye. In one embodiment, the starch-containing starting material is milo. In one embodiment, the starch-containing starting material is sago. In one embodiment, the starch-containing starting material is cassava. In one embodiment, the starch-containing starting material is tapioca. In one embodiment, the starch-containing starting material is sorghum. In one embodiment, the starch-containing starting material is rice. In one embodiment, the starch-containing starting material is peas. In one embodiment, the starch-containing starting material is beans. In one embodiment, the starch-containing starting material is sweet potatoes. In one embodiment, the starch-containing starting material is oats.
  • the methods using a starch-containing material may include a conventional process (e.g., including a liquefaction step described in more detail below) or a raw starch hydrolysis process.
  • a starch-containing material saccharification of the starch-containing material is at a temperature above the initial gelatinization temperature.
  • saccharification of the starch- containing material is at a temperature below the initial gelatinization temperature.
  • the methods may further comprise a liquefaction step carried out by subjecting the starch-containing material at a temperature above the initial gelatinization temperature to an alpha-amylase and optionally a protease and/or a glucoamylase.
  • a liquefaction step carried out by subjecting the starch-containing material at a temperature above the initial gelatinization temperature to an alpha-amylase and optionally a protease and/or a glucoamylase.
  • Other enzymes such as a pullulanase and phytase may also be present and/or added in liquefaction.
  • the liquefaction step is carried out prior to steps a) and b) of the described methods.
  • Liquefaction step may be carried out for 0.5-5 hours, such as 1-3 hours, such as typically about 2 hours.
  • initial gelatinization temperature means the lowest temperature at which gelatinization of the starch-containing material commences.
  • starch heated in water begins to gelatinize between about 50°C and 75°C; the exact temperature of gelatinization depends on the specific starch and can readily be determined by the skilled artisan.
  • the initial gelatinization temperature may vary according to the plant species, to the particular variety of the plant species as well as with the growth conditions.
  • the initial gelatinization temperature of a given starch-containing material may be determined as the temperature at which birefringence is lost in 5% of the starch granules using the method described by Gorinstein and Lii, 1992, Starch/Starke 44(12): 461-466.
  • Liquefaction is typically carried out at a temperature in the range from 70-100°C.
  • the temperature in liquefaction is between 75-95°C, such as between 75- 90°C, between 80-90°C, or between 82-88°C, such as about 85°C.
  • a jet-cooking step may be carried out prior to liquefaction in step, for example, at a temperature between 110-145°C, 120-140°C, 125-135°C, or about 130°C for about 1-15 minutes, for about 3-10 minutes, or about 5 minutes.
  • the pH during liquefaction may be between 4 and 7, such as pH 4.5-6.5, pH 5.0-6.5, pH 5.0-6.0, pH 5.2-6.2, or about 5.2, about 5.4, about 5.6, or about 5.8.
  • the process further comprises, prior to liquefaction, the steps of: i) reducing the particle size of the starch-containing material, preferably by dry milling; ii) forming a slurry comprising the starch-containing material and water.
  • the starch-containing starting material such as whole grains
  • wet and dry milling In dry milling whole kernels are milled and used. Wet milling gives a good separation of germ and meal (starch granules and protein). Wet milling is often applied at locations where the starch hydrolysate is used in production of, e.g., syrups. Both dry milling and wet milling are well known in the art of starch processing.
  • the starch-containing material is subjected to dry milling.
  • the particle size is reduced to between 0.05 to 3.0 mm, e.g., 0.1 -0.5 mm, or so that at least 30%, at least 50%, at least 70%, or at least 90% of the starch-containing material fit through a sieve with a 0.05 to 3.0 mm screen, e.g., 0.1-0.5 mm screen.
  • at least 50%, e.g., at least 70%, at least 80%, or at least 90% of the starch-containing material fit through a sieve with # 6 screen.
  • the aqueous slurry may contain from 10-55 w/w-% dry solids (DS), e.g., 25-45 w/w-% dry solids (DS), or 30-40 w/w-% dry solids (DS) of starch-containing material.
  • DS dry solids
  • the alpha-amylase, optionally a protease, and optionally a glucoamylase may initially be added to the aqueous slurry to initiate liquefaction (thinning). In one embodiment, only a portion of the enzymes (e.g., about 1/3) is added to the aqueous slurry, while the rest of the enzymes (e.g., about 2/3) are added during liquefaction step.
  • Alpha-amylases and glucoamylases used in liquefaction can be found in the art, e.g., W02020/023411 (the content of which is incorporated herein by reference).
  • examples of suitable proteases used in liquefaction can be found in the art, e.g. WO2018/222990 (the content of which is incorporated herein by reference).
  • a glucoamylase may be present and/or added in saccharification step a) and/or fermentation step b) or simultaneous saccharification and fermentation (SSF).
  • the glucoamylase of the saccharification step a) and/or fermentation step b) or simultaneous saccharification and fermentation (SSF) is typically different from the glucoamylase optionally added to any liquefaction step described supra.
  • the glucoamylase is present and/or added together with a fungal alpha-amylase.
  • Suitable glucoamylases used in saccharification or SSF can be found in the art, e.g., W02020/023411 (the content of which is incorporated herein by reference).
  • saccharification step a) may be carried out under conditions well-known in the art. For instance, saccharification step a) may last up to from about 24 to about 72 hours.
  • pre-saccharification is done. Pre-saccharification is typically done for 40-90 minutes at a temperature between 30- 65°C, typically about 60°C. Pre-saccharification is, in one embodiment, followed by saccharification during fermentation in simultaneous saccharification and fermentation (SSF). Saccharification is typically carried out at temperatures from 20-75°C, preferably from 40- 70°C, typically about 60°C, and typically at a pH between 4 and 5, such as about pH 4.5.
  • Fermentation is carried out in a fermentation medium, as known in the art and, e.g., as described herein.
  • the fermentation medium includes the fermentation substrate, that is, the carbohydrate source that is metabolized by the fermenting organism.
  • the fermentation medium may comprise nutrients and growth stimulator(s) for the fermenting organism(s).
  • Nutrient and growth stimulators are widely used in the art of fermentation and include nitrogen sources, such as ammonia; urea, vitamins and minerals, or combinations thereof.
  • the nitrogen source may be organic, such as urea, DDGs, wet cake or corn mash, or inorganic, such as ammonia or ammonium hydroxide. In one embodiment, the nitrogen source is urea.
  • Fermentation can be carried out under low nitrogen conditions, e.g., when using a protease-expressing yeast.
  • the fermentation step is conducted with less than 1000 ppm supplemental nitrogen (e.g., urea or ammonium hydroxide), such as less than 750 ppm, less than 500 ppm, less than 400 ppm, less than 300 ppm, less than 250 ppm, less than 200 ppm, less than 150 ppm, less than 100 ppm, less than 75 ppm, less than 50 ppm, less than 25 ppm, or less than 10 ppm, supplemental nitrogen.
  • the fermentation step is conducted with no supplemental nitrogen.
  • SSF Simultaneous saccharification and fermentation
  • the saccharification step a) and the fermentation step b) are carried out simultaneously.
  • There is no holding stage for the saccharification meaning that a fermenting organism, such as yeast, and enzyme(s), may be added together.
  • a fermenting organism such as yeast, and enzyme(s)
  • SSF is typically carried out at a temperature from 25°C to 40°C, such as from 28°C to 35°C, such as from 30°C to 34°C, or about 32°C.
  • fermentation is ongoing for 6 to 120 hours, in particular 24 to 96 hours.
  • the pH is between 4-5.
  • a cellulolytic enzyme composition is present and/or added in saccharification, fermentation or simultaneous saccharification and fermentation (SSF). Examples of such cellulolytic enzyme compositions can be found in the “Cellulolytic Enzymes and Compositions” section.
  • the cellulolytic enzyme composition may be present and/or added together with a glucoamylase, such as one disclosed in the “Glucoamylases” section.
  • the methods described herein produce a fermentation product from a cellulosic-containing material.
  • the predominant polysaccharide in the primary cell wall of biomass is cellulose, the second most abundant is hemicellulose, and the third is pectin.
  • the secondary cell wall, produced after the cell has stopped growing, also contains polysaccharides and is strengthened by polymeric lignin covalently cross-linked to hemicellulose.
  • Cellulose is a homopolymer of anhydrocellobiose and thus a linear beta-(1-4)- D-glucan, while hemicelluloses include a variety of compounds, such as xylans, xyloglucans, arabinoxylans, and mannans in complex branched structures with a spectrum of substituents. Although generally polymorphous, cellulose is found in plant tissue primarily as an insoluble crystalline matrix of parallel glucan chains. Hemicelluloses usually hydrogen bond to cellulose, as well as to other hemicelluloses, which help stabilize the cell wall matrix.
  • Cellulose is generally found, for example, in the stems, leaves, hulls, husks, and cobs of plants or leaves, branches, and wood of trees.
  • the cellulosic-containing material can be, but is not limited to, agricultural residue, herbaceous material (including energy crops), municipal solid waste, pulp and paper mill residue, waste paper, and wood (including forestry residue) (see, for example, Wiselogel et al., 1995, in Handbook on Bioethanol (Charles E. Wyman, editor), pp.
  • the cellulose may be in the form of lignocellulose, a plant cell wall material containing lignin, cellulose, and hemicellulose in a mixed matrix.
  • the cellulosic-containing material is any biomass material.
  • the cellulosic-containing material is lignocellulose, which comprises cellulose, hemicelluloses, and lignin.
  • the cellulosic-containing material is agricultural residue, herbaceous material (including energy crops), municipal solid waste, pulp and paper mill residue, waste paper, or wood (including forestry residue).
  • the cellulosic-containing material is arundo, bagasse, bamboo, corn cob, corn fiber, corn stover, miscanthus, rice straw, switchgrass, or wheat straw.
  • the cellulosic-containing material is aspen, eucalyptus, fir, pine, poplar, spruce, or willow.
  • the cellulosic-containing material is algal cellulose, bacterial cellulose, cotton linter, filter paper, microcrystalline cellulose (e.g., AVICEL®), or phosphoric- acid treated cellulose.
  • the cellulosic-containing material is an aquatic biomass.
  • aquatic biomass means biomass produced in an aquatic environment by a photosynthesis process.
  • the aquatic biomass can be algae, emergent plants, floatingleaf plants, or submerged plants.
  • the cellulosic-containing material may be used as is or may be subjected to pretreatment, using conventional methods known in the art, as described herein. In a preferred embodiment, the cellulosic-containing material is pretreated.
  • the methods of using cellulosic-containing material can be accomplished using methods conventional in the art. Moreover, the methods of can be implemented using any conventional biomass processing apparatus configured to carry out the processes.
  • the cellulosic-containing material is pretreated before saccharification.
  • any pretreatment process known in the art can be used to disrupt plant cell wall components of the cellulosic-containing material (Chandra et al., 2007, Adv. Biochem. Engin./Biotechnol. 108: 67-93; Galbe and Zacchi, 2007, Adv. Biochem. Engin./Biotechnol. 108: 41-65; Hendriks and Zeeman, 2009, Bioresource Technology 100: 10-18; Mosier et al., 2005, Bioresource Technology 96: 673-686; Taherzadeh and Karimi, 2008, Int. J. Mol. Sci. 9: 1621-1651 ; Yang and Wyman, 2008, Biofuels Bioproducts and Biorefining-Biofpr. 2: 26-40).
  • the cellulosic-containing material can also be subjected to particle size reduction, sieving, pre-soaking, wetting, washing, and/or conditioning prior to pretreatment using methods known in the art.
  • Conventional pretreatments include, but are not limited to, steam pretreatment (with or without explosion), dilute acid pretreatment, hot water pretreatment, alkaline pretreatment, lime pretreatment, wet oxidation, wet explosion, ammonia fiber explosion, organosolv pretreatment, and biological pretreatment.
  • Additional pretreatments include ammonia percolation, ultrasound, electroporation, microwave, supercritical CO2, supercritical H2O, ozone, ionic liquid, and gamma irradiation pretreatments.
  • the cellulosic-containing material is pretreated before saccharification (i.e., hydrolysis) and/or fermentation. Pretreatment is preferably performed prior to the hydrolysis. Alternatively, the pretreatment can be carried out simultaneously with enzyme hydrolysis to release fermentable sugars, such as glucose, xylose, and/or cellobiose. In most cases the pretreatment step itself results in some conversion of biomass to fermentable sugars (even in absence of enzymes). In one embodiment, the cellulosic-containing material is pretreated with steam.
  • the cellulosic-containing material is heated to disrupt the plant cell wall components, including lignin, hemicellulose, and cellulose to make the cellulose and other fractions, e.g., hemicellulose, accessible to enzymes.
  • the cellulosic-containing material is passed to or through a reaction vessel where steam is injected to increase the temperature to the required temperature and pressure and is retained therein for the desired reaction time.
  • Steam pretreatment is preferably performed at 140-250°C, e.g., 160-200°C or 170-190°C, where the optimal temperature range depends on optional addition of a chemical catalyst.
  • Residence time for the steam pretreatment is preferably 1-60 minutes, e.g., 1-30 minutes, 1- 20 minutes, 3-12 minutes, or 4-10 minutes, where the optimal residence time depends on the temperature and optional addition of a chemical catalyst.
  • Steam pretreatment allows for relatively high solids loadings, so that the cellulosic-containing material is generally only moist during the pretreatment.
  • the steam pretreatment is often combined with an explosive discharge of the material after the pretreatment, which is known as steam explosion, that is, rapid flashing to atmospheric pressure and turbulent flow of the material to increase the accessible surface area by fragmentation (Duff and Murray, 1996, Bioresource Technology 855: 1-33; Galbe and Zacchi, 2002, Appl. Microbiol. Biotechnol. 59: 618-628; U.S.
  • Patent Application No. 2002/0164730 During steam pretreatment, hemicellulose acetyl groups are cleaved and the resulting acid autocatalyzes partial hydrolysis of the hemicellulose to monosaccharides and oligosaccharides. Lignin is removed to only a limited extent.
  • the cellulosic-containing material is subjected to a chemical pretreatment.
  • chemical treatment refers to any chemical pretreatment that promotes the separation and/or release of cellulose, hemicellulose, and/or lignin. Such a pretreatment can convert crystalline cellulose to amorphous cellulose.
  • suitable chemical pretreatment processes include, for example, dilute acid pretreatment, lime pretreatment, wet oxidation, ammonia fiber/freeze expansion (AFEX), ammonia percolation (APR), ionic liquid, and organosolv pretreatments.
  • a chemical catalyst such as H2SO4 or SO2 (typically 0.3 to 5% w/w) is sometimes added prior to steam pretreatment, which decreases the time and temperature, increases the recovery, and improves enzymatic hydrolysis (Ballesteros et al., 2006, Appl. Biochem. Biotechnol. 129-132: 496-508; Varga et al., 2004, Appl. Biochem. Biotechnol. 113-116: 509- 523; Sassner et al., 2006, Enzyme Microb. Technol. 39: 756-762).
  • H2SO4 or SO2 typically 0.3 to 5% w/w
  • the cellulosic-containing material is mixed with dilute acid, typically H2SO4, and water to form a slurry, heated by steam to the desired temperature, and after a residence time flashed to atmospheric pressure.
  • the dilute acid pretreatment can be performed with a number of reactor designs, e.g., plug-flow reactors, counter-current reactors, or continuous counter-current shrinking bed reactors (Duff and Murray, 1996, Bioresource Technology 855: 1-33; Schell et al., 2004, Bioresource Technology 91 : 179-188; Lee et al., 1999, Adv. Biochem. Eng. Biotechnol. 65: 93-115).
  • the dilute acid pretreatment of cellulosic- containing material is carried out using 4% w/w sulfuric acid at 180°C for 5 minutes.
  • alkaline pretreatments include, but are not limited to, sodium hydroxide, lime, wet oxidation, ammonia percolation (APR), and ammonia fiber/freeze expansion (AFEX) pretreatment.
  • Lime pretreatment is performed with calcium oxide or calcium hydroxide at temperatures of 85- 150°C and residence times from 1 hour to several days (Wyman et al., 2005, Bioresource Technology 96: 1959-1966; Mosier et al., 2005, Bioresource Technology 96: 673-686).
  • W02006/110891 , W02006/110899, W02006/110900, and W02006/110901 disclose pretreatment methods using ammonia.
  • Wet oxidation is a thermal pretreatment performed typically at 180-200°C for 5-15 minutes with addition of an oxidative agent such as hydrogen peroxide or over-pressure of oxygen (Schmidt and Thomsen, 1998, Bioresource Technology 64: 139-151 ; Palonen et al., 2004, Appl. Biochem. Biotechnol. 117: 1-17; Varga et al., 2004, Biotechnol. Bioeng. 88: 567- 574; Martin et al., 2006, J. Chem. Technol. Biotechnol. 81 : 1669-1677).
  • the pretreatment is performed preferably at 1-40% dry matter, e.g., 2-30% dry matter or 5-20% dry matter, and often the initial pH is increased by the addition of alkali such as sodium carbonate.
  • a modification of the wet oxidation pretreatment method known as wet explosion (combination of wet oxidation and steam explosion) can handle dry matter up to 30%.
  • wet explosion combination of wet oxidation and steam explosion
  • the oxidizing agent is introduced during pretreatment after a certain residence time.
  • the pretreatment is then ended by flashing to atmospheric pressure (W02006/032282).
  • Ammonia fiber expansion involves treating the cellulosic-containing material with liquid or gaseous ammonia at moderate temperatures such as 90-150°C and high pressure such as 17-20 bar for 5-10 minutes, where the dry matter content can be as high as 60% (Gollapalli et al., 2002, Appl. Biochem. Biotechnol. 98: 23-35; Chundawat et al., 2007, Biotechnol. Bioeng. 96: 219-231 ; Alizadeh et al., 2005, Appl. Biochem. Biotechnol. 121 : 1133- 1141 ; Teymouri et al., 2005, Bioresource Technology 96: 2014-2018).
  • cellulose and hemicelluloses remain relatively intact. Lignin-carbohydrate complexes are cleaved.
  • Organosolv pretreatment delignifies the cellulosic-containing material by extraction using aqueous ethanol (40-60% ethanol) at 160-200°C for 30-60 minutes (Pan et al., 2005, Biotechnol. Bioeng. 90: 473-481 ; Pan et al., 2006, Biotechnol. Bioeng. 94: 851-861 ; Kurabi et al., 2005, Appl. Biochem. Biotechnol. 121 : 219-230). Sulphuric acid is usually added as a catalyst. In organosolv pretreatment, the majority of hemicellulose and lignin is removed. Other examples of suitable pretreatment methods are described by Schell et al., 2003, Appl. Biochem. Biotechnol. 105-108: 69-85, and Mosier et al. , 2005, Bioresource Technology 96: 673-686, and US2002/0164730.
  • the chemical pretreatment is carried out as a dilute acid treatment, and more preferably as a continuous dilute acid treatment.
  • the acid is typically sulfuric acid, but other acids can also be used, such as acetic acid, citric acid, nitric acid, phosphoric acid, tartaric acid, succinic acid, hydrogen chloride, or mixtures thereof.
  • Mild acid treatment is conducted in the pH range of preferably 1-5, e.g., 1-4 or 1-2.5.
  • the acid concentration is in the range from preferably 0.01 to 10 wt. % acid, e.g., 0.05 to 5 wt. % acid or 0.1 to 2 wt. % acid.
  • the acid is contacted with the cellulosic-containing material and held at a temperature in the range of preferably 140-200°C, e.g., 165-190°C, for periods ranging from 1 to 60 minutes.
  • pretreatment takes place in an aqueous slurry.
  • the cellulosic-containing material is present during pretreatment in amounts preferably between 10-80 wt. %, e.g., 20-70 wt. % or 30-60 wt. %, such as around 40 wt. %.
  • the pretreated cellulosic-containing material can be unwashed or washed using any method known in the art, e.g., washed with water.
  • the cellulosic-containing material is subjected to mechanical or physical pretreatment.
  • mechanical pretreatment or “physical pretreatment” refers to any pretreatment that promotes size reduction of particles.
  • pretreatment can involve various types of grinding or milling (e.g., dry milling, wet milling, or vibratory ball milling).
  • the cellulosic-containing material can be pretreated both physically (mechanically) and chemically. Mechanical or physical pretreatment can be coupled with steaming/steam explosion, hydrothermolysis, dilute or mild acid treatment, high temperature, high pressure treatment, irradiation (e.g., microwave irradiation), or combinations thereof.
  • high pressure means pressure in the range of preferably about 100 to about 400 psi, e.g., about 150 to about 250 psi.
  • high temperature means temperature in the range of about 100 to about 300°C, e.g., about 140 to about 200°C.
  • mechanical or physical pretreatment is performed in a batch-process using a steam gun hydrolyzer system that uses high pressure and high temperature as defined above, e.g., a Sunds Hydrolyzer available from Sunds Defibrator AB, Sweden.
  • the physical and chemical pretreatments can be carried out sequentially or simultaneously, as desired.
  • the cellulosic-containing material is subjected to physical (mechanical) or chemical pretreatment, or any combination thereof, to promote the separation and/or release of cellulose, hemicellulose, and/or lignin.
  • the cellulosic-containing material is subjected to a biological pretreatment.
  • biological pretreatment refers to any biological pretreatment that promotes the separation and/or release of cellulose, hemicellulose, and/or lignin from the cellulosic-containing material.
  • Bio pretreatment techniques can involve applying ligninsolubilizing microorganisms and/or enzymes (see, for example, Hsu, T.-A., 1996, Pretreatment of biomass, in Handbook on Bioethanol: Production and Utilization, Wyman, C. E., ed., Taylor & Francis, Washington, DC, 179-212; Ghosh and Singh, 1993, Adv. Appl. Microbiol. 39: 295-333; McMillan, J. D., 1994, Pretreating lignocellulosic biomass: a review, in Enzymatic Conversion of Biomass for Fuels Production, Himmel, M. E., Baker, J. O., and Overend, R.
  • Saccharification i.e., hydrolysis
  • fermentation separate or simultaneous, include, but are not limited to, separate hydrolysis and fermentation (SHF); simultaneous saccharification and fermentation (SSF); simultaneous saccharification and co-fermentation (SSCF); hybrid hydrolysis and fermentation (HHF); separate hydrolysis and co-fermentation (SHCF); hybrid hydrolysis and co-fermentation (HHCF).
  • SHF separate hydrolysis and fermentation
  • SSF simultaneous saccharification and fermentation
  • SSCF simultaneous saccharification and co-fermentation
  • HHF hybrid hydrolysis and fermentation
  • SHCF separate hydrolysis and co-fermentation
  • HHCF hybrid hydrolysis and co-fermentation
  • SHF uses separate process steps to first enzymatically hydrolyze the cellulosic- containing material to fermentable sugars, e.g., glucose, cellobiose, and pentose monomers, and then ferment the fermentable sugars to ethanol.
  • fermentable sugars e.g., glucose, cellobiose, and pentose monomers
  • SSCF involves the co-fermentation of multiple sugars (Sheehan and Himmel, 1999, Biotechnol. Prog.
  • HHF involves a separate hydrolysis step, and in addition a simultaneous saccharification and hydrolysis step, which can be carried out in the same reactor.
  • the steps in an HHF process can be carried out at different temperatures, i.e., high temperature enzymatic saccharification followed by SSF at a lower temperature that the fermentation organismcan tolerate. It is understood herein that any method known in the art comprising pretreatment, enzymatic hydrolysis (saccharification), fermentation, or a combination thereof, can be used in the practicing the processes described herein.
  • a conventional apparatus can include a fed-batch stirred reactor, a batch stirred reactor, a continuous flow stirred reactor with ultrafiltration, and/or a continuous plug-flow column reactor (de Castilhos Corazza et al., 2003, Acta Scientiarum. Technology 25: 33-38; Gusakov and Sinitsyn, 1985, Enz. Microb. Technol. 7: 346-352), an attrition reactor (Ryu and Lee, 1983, Biotechnol. Bioeng. 25: 53-65). Additional reactor types include fluidized bed, upflow blanket, immobilized, and extruder type reactors for hydrolysis and/or fermentation.
  • the cellulosic and/or starch- containing material e.g., pretreated
  • the hydrolysis is performed enzymatically e.g., by a cellulolytic enzyme composition.
  • the enzymes of the compositions can be added simultaneously or sequentially.
  • Enzymatic hydrolysis may be carried out in a suitable aqueous environment under conditions that can be readily determined by one skilled in the art.
  • hydrolysis is performed under conditions suitable for the activity of the enzymes(s), i.e., optimal for the enzyme(s).
  • the hydrolysis can be carried out as a fed batch or continuous process where the cellulosic and/or starch-containing material is fed gradually to, for example, an enzyme containing hydrolysis solution.
  • the saccharification is generally performed in stirred-tank reactors orfermentors under controlled pH, temperature, and mixing conditions. Suitable process time, temperature and pH conditions can readily be determined by one skilled in the art.
  • the saccharification can last up to 200 hours, but is typically performed for preferably about 12 to about 120 hours, e.g., about 16 to about 72 hours or about 24 to about 48 hours.
  • the temperature is in the range of preferably about 25°C to about 70°C, e.g., about 30°C to about 65°C, about 40°C to about 60°C, or about 50°C to about 55°C.
  • the pH is in the range of preferably about 3 to about 8, e.g., about 3.5 to about 7, about 4 to about 6, or about 4.5 to about 5.5.
  • the dry solids content is in the range of preferably about 5 to about 50 wt. %, e.g., about 10 to about 40 wt. % or about 20 to about 30 wt. %.
  • the cellulolytic enzyme compositions can comprise any protein useful in degrading the cellulosic-containing material.
  • the cellulolytic enzyme composition comprises or further comprises one or more (e.g., several) proteins selected from the group consisting of a cellulase, an AA9 (GH61) polypeptide, a hemicellulase, an esterase, an expansin, a ligninolytic enzyme, an oxidoreductase, a pectinase, a protease, and a swollenin.
  • the cellulase is preferably one or more (e.g., several) enzymes selected from the group consisting of an endoglucanase, a cellobiohydrolase, and a betaglucosidase.
  • the hemicellulase is preferably one or more (e.g., several) enzymes selected from the group consisting of an acetylmannan esterase, an acetylxylan esterase, an arabinanase, an arabinofuranosidase, a coumaric acid esterase, a feruloyl esterase, a galactosidase, a glucuronidase, a glucuronoyl esterase, a mannanase, a mannosidase, a xylanase, and a xylosidase.
  • the oxidoreductase is one or more (e.g., several) enzymes selected from the group consisting of a catalase, a laccase, and a peroxidase.
  • the enzymes or enzyme compositions used in a processes of the present invention may be in any form suitable for use, such as, for example, a fermentation broth formulation or a cell composition, a cell lysate with or without cellular debris, a semi-purified or purified enzyme preparation, or a host cell as a source of the enzymes.
  • the enzyme composition may be a dry powder or granulate, a non-dusting granulate, a liquid, a stabilized liquid, or a stabilized protected enzyme.
  • Liquid enzyme preparations may, for instance, be stabilized by adding stabilizers such as a sugar, a sugar alcohol or another polyol, and/or lactic acid or another organic acid according to established processes.
  • an effective amount of cellulolytic or hemicellulolytic enzyme composition to the cellulosic-containing material is about 0.5 to about 50 mg, e.g., about 0.5 to about 40 mg, about 0.5 to about 25 mg, about 0.75 to about 20 mg, about 0.75 to about 15 mg, about 0.5 to about 10 mg, or about 2.5 to about 10 mg per g of the cellulosic-containing material.
  • such a compound is added at a molar ratio of the compound to glucosyl units of cellulose of about 10 -6 to about 10, e.g., about 10' 6 to about 7.5, about 10' 6 to about 5, about 10' 6 to about 2.5, about 10' 6 to about 1 , about 10' 5 to about 1 , about 10' 5 to about 10’ 1 , about 10' 4 to about 10’ 1 , about 10' 3 to about 10’ 1 , or about 10' 3 to about 10' 2 .
  • an effective amount of such a compound is about 0.1 pM to about 1 M, e.g., about 0.5 pM to about 0.75 M, about 0.75 pM to about 0.5 M, about 1 pM to about 0.25 M, about 1 pM to about 0.1 M, about 5 pM to about 50 mM, about 10 pM to about 25 mM, about 50 pM to about 25 mM, about 10 pM to about 10 mM, about 5 pM to about 5 mM, or about 0.1 mM to about 1 mM.
  • liquid means the solution phase, either aqueous, organic, or a combination thereof, arising from treatment of a lignocellulose and/or hemicellulose material in a slurry, or monosaccharides thereof, e.g., xylose, arabinose, mannose, etc. under conditions as described in WO2012/021401 , and the soluble contents thereof.
  • a liquor for cellulolytic enhancement of an AA9 polypeptide can be produced by treating a lignocellulose or hemicellulose material (or feedstock) by applying heat and/or pressure, optionally in the presence of a catalyst, e.g., acid, optionally in the presence of an organic solvent, and optionally in combination with physical disruption of the material, and then separating the solution from the residual solids.
  • a catalyst e.g., acid
  • organic solvent optionally in the presence of an organic solvent
  • the liquor can be separated from the treated material using a method standard in the art, such as filtration, sedimentation, or centrifugation.
  • an effective amount of the liquor to cellulose is about 10 -6 to about 10 g per g of cellulose, e.g., about 10' 6 to about 7.5 g, about 10' 6 to about 5 g, about 10' 6 to about 2.5 g, about 10 -6 to about 1 g, about 10' 5 to about 1 g, about 10' 5 to about 10' 1 g, about 10 -4 to about 10' 1 g, about 10' 3 to about 10' 1 g, or about 10' 3 to about 10' 2 g per g of cellulose.
  • sugars released from the cellulosic-containing material, e.g., as a result of the pretreatment and enzymatic hydrolysis steps, are fermented to ethanol, by a fermenting organism, such as yeast described herein.
  • Hydrolysis (saccharification) and fermentation can be separate or simultaneous.
  • Any suitable hydrolyzed cellulosic-containing material can be used in the fermentation step in practicing the processes described herein.
  • feedstocks include, but are not limited to carbohydrates (e.g., lignocellulose, xylans, cellulose, starch, etc.).
  • the material is generally selected based on economics, /.e., costs per equivalent sugar potential, and recalcitrance to enzymatic conversion.
  • compositions of the fermentation media and fermentation conditions depend on the fermenting organism and can easily be determined by one skilled in the art.
  • the fermentation takes place under conditions known to be suitable for generating the fermentation product.
  • the fermentation process is carried out under aerobic or microaerophilic (i.e. , where the concentration of oxygen is less than that in air), or anaerobic conditions.
  • fermentation is conducted under anaerobic conditions (i.e., no detectable oxygen), or less than about 5, about 2.5, or about 1 mmol/L/h oxygen.
  • anaerobic conditions i.e., no detectable oxygen
  • the NADH produced in glycolysis cannot be oxidized by oxidative phosphorylation.
  • pyruvate or a derivative thereof may be utilized by the fermenting organism as an electron and hydrogen acceptor in order to generate NAD+.
  • the fermentation process is typically run at a temperature that is optimal for the cell.
  • the fermentation process is performed at a temperature in the range of from about 25°C to about 42°C.
  • the process is carried out a temperature that is less than about 38°C, less than about 35°C, less than about 33°C, or less than about 38°C, but at least about 20°C, 22°C, or 25°C.
  • a fermentation stimulator can be used in a process described herein to further improve the fermentation, and in particular, the performance of the fermenting organism, such as, rate enhancement and product yield (e.g., ethanol yield).
  • a “fermentation stimulator” refers to stimulators for growth of the fermenting organisms, in particular, yeast.
  • Preferred fermentation stimulators for growth include vitamins and minerals. Examples of vitamins include multivitamins, biotin, pantothenate, nicotinic acid, meso-inositol, thiamine, pyridoxine, paraaminobenzoic acid, folic acid, riboflavin, and Vitamins A, B, C, D, and E.
  • minerals include minerals and mineral salts that can supply nutrients comprising P, K, Mg, S, Ca, Fe, Zn, Mn, and Cu.
  • a cellulolytic enzyme or cellulolytic enzyme composition may be present and/or added during saccharification.
  • a cellulolytic enzyme composition is an enzyme preparation containing one or more (e.g., several) enzymes that hydrolyze cellulosic-containing material. Such enzymes include endoglucanase, cellobiohydrolase, beta-glucosidase, and/or combinations thereof.
  • the fermenting organism comprises one or more (e.g., several) heterologous polynucleotides encoding enzymes that hydrolyze cellulosic-containing material (e.g., an endoglucanase, cellobiohydrolase, beta-glucosidase or combinations thereof). Any enzyme described or referenced herein that hydrolyzes cellulosic-containing material is contemplated for expression in the fermenting organism.
  • the cellulolytic enzyme may be any cellulolytic enzyme that is suitable for the expression in the fermenting organism and/or the methods described herein (e.g., an endoglucanase, cellobiohydrolase, beta-glucosidase), such as a naturally occurring cellulolytic enzyme or a variant thereof that retains cellulolytic enzyme activity.
  • the fermenting organism comprising a heterologous polynucleotide encoding a cellulolytic enzyme has an increased level of cellulolytic enzyme activity (e.g., increased endoglucanase, cellobiohydrolase, and/or beta-glucosidase) compared to the fermenting organisms without the heterologous polynucleotide encoding the cellulolytic enzyme, when cultivated under the same conditions.
  • increased level of cellulolytic enzyme activity e.g., increased endoglucanase, cellobiohydrolase, and/or beta-glucosidase
  • the fermenting organism has an increased level of cellulolytic enzyme activity of at least 5%, e.g., at least 10%, at least 15%, at least 20%, at least 25%, at least 50%, at least 100%, at least 150%, at least 200%, at least 300%, or at 500% compared to the fermenting organism without the heterologous polynucleotide encoding the cellulolytic enzyme, when cultivated under the same conditions.
  • Exemplary cellulolytic enzymes that can be used with the fermenting organisms and/or the methods described herein include bacterial, yeast, or filamentous fungal cellulolytic enzymes, e.g., obtained from any of the microorganisms described or referenced herein, as described supra under the sections related to proteases.
  • the cellulolytic enzyme may be of any origin.
  • the cellulolytic enzyme is derived from a strain of Trichoderma, such as a strain of Trichoderma reeser, a strain of Humicola, such as a strain of Humicola insolens, and/or a strain of Chrysosporium, such as a strain of Chrysosporium lucknowense.
  • the cellulolytic enzyme is derived from a strain of Trichoderma reesei.
  • the cellulolytic enzyme composition may further comprise one or more of the following polypeptides, such as enzymes: AA9 polypeptide (GH61 polypeptide) having cellulolytic enhancing activity, beta-glucosidase, xylanase, beta-xylosidase, CBH I, CBH II, or a mixture of two, three, four, five or six thereof.
  • AA9 polypeptide GH61 polypeptide having cellulolytic enhancing activity
  • beta-glucosidase xylanase
  • beta-xylosidase CBH I, CBH II
  • CBH I CBH I
  • CBH II CBH II
  • the further polypeptide(s) e.g., AA9 polypeptide
  • enzyme(s) e.g., betaglucosidase, xylanase, beta-xylosidase, CBH I and/or CBH II
  • CBH I and/or CBH II may be foreign to the cellulolytic enzyme composition producing organism (e.g., Trichoderma reesei).
  • the cellulolytic enzyme composition comprises an AA9 polypeptide having cellulolytic enhancing activity and a beta-glucosidase.
  • the cellulolytic enzyme composition comprises an AA9 polypeptide having cellulolytic enhancing activity, a beta-glucosidase, and a CBH I.
  • the cellulolytic enzyme composition comprises an AA9 polypeptide having cellulolytic enhancing activity, a beta-glucosidase, a CBH I and a CBH II.
  • Other enzymes, such as endoglucanases, may also be comprised in the cellulolytic enzyme composition.
  • the cellulolytic enzyme composition may comprise a number of difference polypeptides, including enzymes.
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising Thermoascus aurantiacus AA9 (GH61A) polypeptide having cellulolytic enhancing activity (e.g., W02005/074656), and Aspergillus oryzae beta-glucosidase fusion protein (e.g., one disclosed in W02008/057637, in particular shown as SEQ ID NOs: 59 and 60).
  • G61A Thermoascus aurantiacus AA9
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising Thermoascus aurantiacus AA9 (GH61A) polypeptide having cellulolytic enhancing activity (e.g., SEQ ID NO: 2 in W02005/074656), and Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499).
  • G61A Thermoascus aurantiacus AA9
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, in particular the one disclosed in WO2011/041397, and Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499).
  • G61A Penicillium emersonii AA9
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, in particular the one disclosed in WQ2011/041397, and Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499) or a variant disclosed in WQ2012/044915 (hereby incorporated by reference), in particular one comprising one or more such as all of the following substitutions: F100D, S283G, N456E, F512Y.
  • G61A Penicillium emersonii AA9
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic composition, further comprising an AA9 (GH61A) polypeptide having cellulolytic enhancing activity, in particular the one derived from a strain of Penicillium emersonii (e.g., SEQ ID NO: 2 in WQ2011/041397), Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 in WQ2005/047499) variant with one or more, in particular all of the following substitutions: F100D, S283G, N456E, F512Y and disclosed in WQ2012/044915; Aspergillus fumigatus Cel7A CBH1 , e.g., the one disclosed as SEQ ID NO: 6 in WQ2011/057140 and Aspergillus fumigatus CBH II, e.g., the one disclosed as SEQ ID NO: 18 in WQ2011/057140.
  • G9 G
  • the cellulolytic enzyme composition is a Trichoderma reesei, cellulolytic enzyme composition, further comprising a hemicellulase or hemicellulolytic enzyme composition, such as an Aspergillus fumigatus xylanase and Aspergillus fumigatus beta-xylosidase.
  • the cellulolytic enzyme composition also comprises a xylanase (e.g., derived from a strain of the genus Aspergillus, in particular Aspergillus aculeatus or Aspergillus fumigatus; or a strain of the genus Talaromyces, in particular Talaromyces leycettanus) and/or a beta-xylosidase (e.g., derived from Aspergillus, in particular Aspergillus fumigatus, or a strain of Talaromyces, in particular Talaromyces emersonii).
  • a xylanase e.g., derived from a strain of the genus Aspergillus, in particular Aspergillus aculeatus or Aspergillus fumigatus
  • beta-xylosidase e.g
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising Thermoascus aurantiacus AA9 (GH61A) polypeptide having cellulolytic enhancing activity (e.g., WQ2005/074656), Aspergillus oryzae beta-glucosidase fusion protein (e.g., one disclosed in WQ2008/057637, in particular as SEQ ID NOs: 59 and 60), and Aspergillus aculeatus xylanase (e.g., Xyl II in WO94/21785).
  • G61A Thermoascus aurantiacus AA9
  • the cellulolytic enzyme composition comprises a Trichoderma reesei cellulolytic preparation, further comprising Thermoascus aurantiacus GH61A polypeptide having cellulolytic enhancing activity (e.g., SEQ ID NO: 2 in W02005/074656), Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499) and Aspergillus aculeatus xylanase (Xyl II disclosed in WO94/21785).
  • Thermoascus aurantiacus GH61A polypeptide having cellulolytic enhancing activity e.g., SEQ ID NO: 2 in W02005/074656
  • Aspergillus fumigatus beta-glucosidase e.g., SEQ ID NO: 2 of WQ2005/047499
  • Aspergillus aculeatus xylanase
  • the cellulolytic enzyme composition comprises a Trichoderma reesei cellulolytic enzyme composition, further comprising Thermoascus aurantiacus AA9 (GH61A) polypeptide having cellulolytic enhancing activity (e.g., SEQ ID NO: 2 in WQ2005/074656), Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499) and Aspergillus aculeatus xylanase (e.g., Xyl II disclosed in WO94/21785).
  • G61A Thermoascus aurantiacus AA9
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, in particular the one disclosed in WQ2011/041397, Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499) and Aspergillus fumigatus xylanase (e.g., Xyl III in WQ2006/078256).
  • Penicillium emersonii AA9 G61A polypeptide having cellulolytic enhancing activity, in particular the one disclosed in WQ2011/041397, Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499) and Aspergillus fumigatus xylanase (e.g., Xyl III
  • the cellulolytic enzyme composition comprises a Trichoderma reesei cellulolytic enzyme composition, further comprising Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, in particular the one disclosed in WQ2011/041397, Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499), Aspergillus fumigatus xylanase (e.g., Xyl III in WO2006/078256), and CBH I from Aspergillus fumigatus, in particular Cel7A CBH1 disclosed as SEQ ID NO: 2 in WQ2011/057140.
  • G61A Penicillium emersonii AA9
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, in particular the one disclosed in WQ2011/041397, Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499), Aspergillus fumigatus xylanase (e.g., Xyl III in WQ2006/078256), CBH I from Aspergillus fumigatus, in particular Cel7A CBH1 disclosed as SEQ ID NO: 2 in WQ2011/057140, and CBH II derived from Aspergillus fumigatus in particular the one disclosed as SEQ ID NO: 4 in WQ2013/028928.
  • G61A Penicillium emersonii AA9
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising Penicillium emersonii AA9 (GH61A) polypeptide having cellulolytic enhancing activity, in particular the one disclosed in WQ2011/041397, Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WQ2005/047499) or variant thereof with one or more, in particular all, of the following substitutions: F100D, S283G, N456E, F512Y; Aspergillus fumigatus xylanase (e.g., Xyl III in WQ2006/078256), CBH I from Aspergillus fumigatus, in particular Cel7A CBH I disclosed as SEQ ID NO: 2 in WO2011/057140, and CBH II derived from Aspergillus fumigatus, in particular the one disclosed in WO2013/028928.
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition
  • the CBH I (GENSEQP Accession No. AZY49536 (WO2012/103293); a CBH II (GENSEQP Accession No. AZY49446 (WO2012/103288); a beta-glucosidase variant (GENSEQP Accession No. AZU67153 (WO2012/44915)), in particular with one or more, in particular all, of the following substitutions: F100D, S283G, N456E, F512Y; and AA9 (GH61 polypeptide) (GENSEQP Accession No. BAL61510 (WQ2013/028912)).
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition comprising a CBH I (GENSEQP Accession No. AZY49536 (WQ2012/103293)); a CBH II (GENSEQP Accession No. AZY49446 (WQ2012/103288); a GH10 xylanase (GENSEQP Accession No. BAK46118 (WQ2013/019827)); and a beta- xylosidase (GENSEQP Accession No. AZI04896 (WQ2011/057140)).
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition comprising a CBH I (GENSEQP Accession No. AZY49536 (WQ2012/103293)); a CBH II (GENSEQP Accession No. AZY49446 (WQ2012/103288)); and an AA9 (GH61 polypeptide; GENSEQP Accession No. BAL61510 (WQ2013/028912)).
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition comprising a CBH I (GENSEQP Accession No. AZY49536 (WQ2012/103293)); a CBH II (GENSEQP Accession No. AZY49446 (WQ2012/103288)), an AA9 (GH61 polypeptide; GENSEQP Accession No. BAL61510 (WQ2013/028912)), and a catalase (GENSEQP Accession No. BAC11005 (WQ2012/130120)).
  • the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition
  • a CBH I (GENSEQP Accession No. AZY49446 (WQ2012/103288); a CBH II (GENSEQP Accession No. AZY49446 (WQ2012/103288)), a beta-glucosidase variant (GENSEQP Accession No. AZU67153 (WO2012/44915)), with one or more, in particular all, of the following substitutions: F100D, S283G, N456E, F512Y; an AA9 (GH61 polypeptide; GENSEQP Accession No.
  • BAL61510 (WQ2013/028912)
  • a GH10 xylanase (GENSEQP Accession No. BAK46118 (WQ2013/019827)
  • a beta-xylosidase (GENSEQP Accession No. AZI04896 (WQ2011/057140)).
  • the cellulolytic composition is a Trichoderma reesei cellulolytic enzyme preparation comprising an EG I (Swissprot Accession No. P07981), EG II (EM BL Accession No. M 19373), CBH I (supra , CBH II (supray beta-glucosidase variant (supra) with the following substitutions: F100D, S283G, N456E, F512Y; an AA9 (GH61 polypeptide; supra), GH10 xylanase (supray, and beta-xylosidase (supra). All cellulolytic enzyme compositions disclosed in WO2013/028928 are also contemplated and hereby incorporated by reference.
  • the cellulolytic enzyme composition comprises or may further comprise one or more (several) proteins selected from the group consisting of a cellulase, a AA9 (i.e., GH61) polypeptide having cellulolytic enhancing activity, a hemicellulase, an expansin, an esterase, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.
  • a cellulase a AA9 (i.e., GH61) polypeptide having cellulolytic enhancing activity
  • a hemicellulase an expansin
  • an esterase a laccase
  • a ligninolytic enzyme a pectinase
  • peroxidase a peroxidase
  • protease and a swollenin.
  • the cellulolytic enzyme composition is a commercial cellulolytic enzyme composition.
  • commercial cellulolytic enzyme compositions suitable for use in a process of the invention include: CELLIC® CTec (Novozymes A/S), CELLIC® CTec2 (Novozymes A/S), CELLIC® CTec3 (Novozymes A/S), CELLUCLASTTM (Novozymes A/S), SPEZYMETM CP (Genencor Int.), ACCELLERASETM 1000, ACCELLERASE 1500, ACCELLERASETM TRIO (DuPont), FILTRASE® NL (DSM); METHAPLUS® S/L 100 (DSM), ROHAMENTTM 7069 W (Rohm GmbH), or ALTERNAFUEL® CMAX3TM (Dyadic International, Inc.).
  • the cellulolytic enzyme composition may be added in an amount effective from about 0.001 to about 5.0 wt. % of solids, e.g., about 0.025 to about 4.0 wt. % of solids or about 0.005 to about 2.0 wt. % of solids.
  • Additional polynucleotides encoding suitable cellulolytic enzymes may be obtained from microorganisms of any genus, including those readily available within the UniProtKB database (www.uniprot.org).
  • the cellulolytic enzyme coding sequences can also be used to design nucleic acid probes to identify and clone DNA encoding cellulolytic enzymes from strains of different genera or species are known in the art.
  • polynucleotides encoding cellulolytic enzymes may also be identified and obtained from other sources including microorganisms isolated from nature (e.g., soil, composts, water, etc.) or DNA samples obtained directly from natural materials (e.g., soil, composts, water, etc.) are known in the art.
  • the cellulolytic enzyme has a mature polypeptide sequence of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to any cellulolytic enzyme described or referenced herein (e.g., any endoglucanase, cellobiohydrolase, or betaglucosidase).
  • any cellulolytic enzyme described or referenced herein e.g., any endoglucanase, cellobiohydrolase, or betaglucosidase.
  • the cellulolytic enzyme ha a mature polypeptide sequence that differs by no more than ten amino acids, e.g., by no more than five amino acids, by no more than four amino acids, by no more than three amino acids, by no more than two amino acids, or by one amino acid from any cellulolytic enzyme described or referenced herein.
  • the cellulolytic enzyme has a mature polypeptide sequence that comprises or consists of the amino acid sequence of any cellulolytic enzyme described or referenced herein, allelic variant, or a fragment thereof having cellulolytic enzyme activity.
  • the cellulolytic enzyme has an amino acid substitution, deletion, and/or insertion of one or more (e.g., two, several) amino acids. In some embodiments, the total number of amino acid substitutions, deletions and/or insertions is not more than 10, e.g., not more than 9, 8, 7, 6, 5, 4, 3, 2, or 1.
  • the cellulolytic enzyme has at least 20%, e.g., at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% of the cellulolytic enzyme activity of any cellulolytic enzyme described or referenced herein (e.g., any endoglucanase, cellobiohydrolase, or beta-glucosidase) under the same conditions.
  • any cellulolytic enzyme described or referenced herein e.g., any endoglucanase, cellobiohydrolase, or beta-glucosidase
  • the cellulolytic enzyme coding sequence hybridizes under at least low stringency conditions, e.g., medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with the full-length complementary strand of the coding sequence from any cellulolytic enzyme described or referenced herein (e.g., any endoglucanase, cellobiohydrolase, or beta-glucosidase).
  • low stringency conditions e.g., medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions
  • any cellulolytic enzyme described or referenced herein e.g., any endoglucanase, cellobiohydrolase, or beta-glucosidase.
  • the cellulolytic enzyme coding sequence has at least 65%, e.g., at least 70%, at least 75%, at least 80%, at least 85%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the coding sequence from any cellulolytic enzyme described or referenced herein.
  • the polynucleotide encoding the cellulolytic enzyme comprises the coding sequence of any cellulolytic enzyme described or referenced herein (e.g., any endoglucanase, cellobiohydrolase, or beta-glucosidase).
  • the polynucleotide encoding the cellulolytic enzyme comprises a subsequence of the coding sequence from any cellulolytic enzyme described or referenced herein, wherein the subsequence encodes a polypeptide having cellulolytic enzyme activity.
  • the number of nucleotides residues in the subsequence is at least 75%, e.g., at least 80%, 85%, 90%, or 95% of the number of the referenced coding sequence.
  • the cellulolytic enzyme can also include fused polypeptides or cleavable fusion polypeptides. Fermentation products
  • a fermentation product can be any substance derived from the fermentation.
  • the fermentation product can be, without limitation, an alcohol (e.g., arabinitol, n-butanol, isobutanol, ethanol, glycerol, methanol, ethylene glycol, 1 ,3-propanediol [propylene glycol], butanediol, glycerin, sorbitol, and xylitol); an alkane (e.g., pentane, hexane, heptane, octane, nonane, decane, undecane, and dodecane), a cycloalkane (e.g., cyclopentane, cyclohexane, cycloheptane, and cyclooctane), an alkene (e.g., pentene, hexene, heptene, and octene); an amino acid (
  • the fermentation product is an alcohol.
  • alcohol encompasses a substance that contains one or more hydroxyl moieties.
  • the alcohol can be, but is not limited to, n-butanol, isobutanol, ethanol, methanol, arabinitol, butanediol, ethylene glycol, glycerin, glycerol, 1 ,3-propanediol, sorbitol, xylitol.
  • the fermentation product is ethanol.
  • the fermentation product is an alkane.
  • the alkane may be an unbranched or a branched alkane.
  • the alkane can be, but is not limited to, pentane, hexane, heptane, octane, nonane, decane, undecane, or dodecane.
  • the fermentation product is a cycloalkane.
  • the cycloalkane can be, but is not limited to, cyclopentane, cyclohexane, cycloheptane, or cyclooctane.
  • the fermentation product is an alkene.
  • the alkene may be an unbranched or a branched alkene.
  • the alkene can be, but is not limited to, pentene, hexene, heptene, or octene.
  • the fermentation product is an amino acid.
  • the organic acid can be, but is not limited to, aspartic acid, glutamic acid, glycine, lysine, serine, or threonine. See, for example, Richard and Margaritis, 2004, Biotechnology and Bioengineering 87(4): 501-515.
  • the fermentation product is a gas.
  • the gas can be, but is not limited to, methane, H2, CO2, or CO. See, for example, Kataoka et al., 1997, Water Science and Technology 36(6-7): 41-47; and Gunaseelan, 1997, Biomass and Bioenergy 13(1-2): 83- 114.
  • the fermentation product is isoprene.
  • the fermentation product is a ketone.
  • ketone encompasses a substance that contains one or more ketone moieties.
  • the ketone can be, but is not limited to, acetone.
  • the fermentation product is an organic acid.
  • the organic acid can be, but is not limited to, acetic acid, acetonic acid, adipic acid, ascorbic acid, citric acid, 2,5-diketo-D-gluconic acid, formic acid, fumaric acid, glucaric acid, gluconic acid, glucuronic acid, glutaric acid, 3-hydroxypropionic acid, itaconic acid, lactic acid, malic acid, malonic acid, oxalic acid, propionic acid, succinic acid, or xylonic acid. See, for example, Chen and Lee, 1997, Appl. Biochem. Biotechnol. 63-65: 435-448.
  • the fermentation product is polyketide
  • the fermentation product e.g., ethanol
  • alcohol is separated from the fermented cellulosic material and purified by conventional methods of distillation. Ethanol with a purity of up to about 96 vol. % can be obtained, which can be used as, for example, fuel ethanol, drinking ethanol, /.e., potable neutral spirits, or industrial ethanol.
  • the fermentation product after being recovered is substantially pure.
  • substantially pure intends a recovered preparation that contains no more than 15% impurity, wherein impurity intends compounds other than the fermentation product (e.g., ethanol).
  • a substantially pure preparation is provided wherein the preparation contains no more than 25% impurity, or no more than 20% impurity, or no more than 10% impurity, or no more than 5% impurity, or no more than 3% impurity, or no more than 1 % impurity, or no more than 0.5% impurity.
  • Suitable assays to test for the production of ethanol and contaminants, and sugar consumption can be performed using methods known in the art.
  • ethanol product, as well as other organic compounds can be analyzed by methods such as HPLC (High Performance Liquid Chromatography), GC-MS (Gas Chromatography Mass Spectroscopy) and LC-MS (Liquid Chromatography-Mass Spectroscopy) or other suitable analytical methods using routine procedures well known in the art.
  • HPLC High Performance Liquid Chromatography
  • GC-MS Gas Chromatography Mass Spectroscopy
  • LC-MS Liquid Chromatography-Mass Spectroscopy
  • Byproducts and residual sugar in the fermentation medium can be quantified by HPLC using, for example, a refractive index detector for glucose and alcohols, and a UV detector for organic acids (Lin et al., Biotechnol. Bioeng. 90:775 -779 (2005)), or using other suitable assay and detection methods well known in the art.
  • the strains were deposited under conditions that assure that access to the culture will be available during the pendency of this patent application to one determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 C.F.R. ⁇ 1.14 and 35 U.S.C. ⁇ 122.
  • the deposit represents a substantially pure culture of the deposited strain.
  • the deposit is available as required by foreign patent laws in countries wherein counterparts of the subject application, or its progeny are filed. However, it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action.
  • Example 1 Production of Saccharomyces cerevisiae strains MBG5225, MBG5227, MBG5318 and MBG5307
  • Strains MBG5225, MBG5227, MBG5307 and MBG5318 were derived from breeding and evolutionary programs (e.g., according to the breeding procedures described in US Patent No. 8,257,959) that targeted improved fermentation performance with regards to features of importance to the industrial production of corn ethanol. Resulting strains were screened for improved ethanol titres, increased temperature tolerance, increased sugar consumption, high ethanol to glycerol ratios, and reduced by-products to maximize the yield of ethanol from corn mash fermentations.
  • Example 2 Fermentation of Saccharomyces cerevisiae strain MBG5225 under nonstress conditions
  • Saccharomyces cerevisiae strains MBG5225 and Ethanol Red® were fermented under the following conditions:
  • Glucoamylose Spirizyme Achieve T (Novozymes A/S)
  • Glucoamylose dose 0.6 AGU/g DS
  • Saccharomyces cerevisiae strain MBG5225 demonstrated improved ethanol yields and decreased glycerol levels when compared to Ethanol Red®.
  • Example 3 Fermentation of Saccharomyces cerevisiae strain MBG5227 under nonstress conditions
  • Saccharomyces cerevisiae strains MBG5227 and Ethanol Red® were fermented under the following conditions:
  • Glucoamylose Spirizyme Achieve T (Novozymes A/S)
  • Glucoamylose dose 0.6 AGU/g DS
  • Saccharomyces cerevisiae strain MBG5227 demonstrated improved ethanol yields and decreased glycerol levels when compared to Ethanol Red®.
  • Saccharomyces cerevisiae strains MBG5318 and Ethanol Red® were fermented under the following conditions:
  • Glucoamylose Spirizyme Achieve T (Novozymes A/S)
  • Glucoamylose dose 0.6 AGU/g DS
  • Saccharomyces cerevisiae strain MBG5318 demonstrated improved ethanol yields and decreased glycerol levels when compared to Ethanol Red®.
  • Example 5 Fermentation of Saccharomyces cerevisiae strain MBG5307 under nonstress conditions
  • Saccharomyces cerevisiae strains MBG5307 and Ethanol Red® were fermented under the following conditions:
  • Glucoamylose Spirizyme Achieve T (Novozymes A/S)
  • Glucoamylose dose 0.6 AGU/g DS
  • Saccharomyces cerevisiae strain MBG5307 demonstrated improved ethanol yields and decreased glycerol levels when compared to Ethanol Red®.
  • Saccharomyces cerevisiae strains MBG5225 and Ethanol Red® were fermented under the following conditions:
  • Glucoamylose Spirizyme Achieve T (Novozymes A/S)
  • Glucoamylose dose 0.6 AGU/g DS
  • Saccharomyces cerevisiae strain MBG5225 demonstrated improved ethanol yield when compared to Ethanol Red® in the prescence of organic acids (lactic + acetic acid and higher temperatures).
  • Example 7 Fermentation of Saccharomyces cerevisiae strain MBG5227 under stress conditions
  • Saccharomyces cerevisiae strains MBG5227 and Ethanol Red® were fermented under the following conditions:
  • Glucoamylose Spirizyme Achieve T (Novozymes A/S)
  • Glucoamylose dose 0.6 AGU/g DS
  • Saccharomyces cerevisiae strain MBG5227 demonstrated improved ethanol yield when compared to Ethanol Red® in the prescence of organic acids (lactic + acetic acid and higher temperatures).
  • Example 8 Fermentation of Saccharomyces cerevisiae strain MBG5318 under stress conditions
  • Saccharomyces cerevisiae strains MBG5318 and Ethanol Red® were fermented under the following conditions:
  • Glucoamylose Spirizyme Achieve T (Novozymes A/S)
  • Glucoamylose dose 0.6 AGU/g DS
  • Saccharomyces cerevisiae strain MBG5318 demonstrated improved ethanol yield when compared to Ethanol Red® in the prescence of organic acids (lactic + acetic acid and higher temperatures).
  • a method of producing a fermentation product from a cellulosic-containing and/or starch-containing material comprising:
  • step (b) fermenting the saccharified material of step (a) with a fermenting organism under suitable conditions to produce the fermentation product; wherein the fermenting organism is a strain of Saccharomyces cerevisiae deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no. NRRL Y- 68199 (Saccharomyces cerevisiae strain MBG5225), or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase) or a fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae MBG5225.
  • NRRL Agricultural Research Service Patent Culture Collection
  • a method of producing a fermentation product from a cellulosic-containing and/or starch-containing material comprising:
  • step (a) saccharifying the cellulosic-containing or starch-containing material; and (b) fermenting the saccharified material of step (a) with a fermenting organism under suitable conditions to produce the fermentation product; wherein the fermenting organism is a strain of Saccharomyces cerevisiae deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no.
  • NRRL Agricultural Research Service Patent Culture Collection
  • NRRL Y- 68200 Sacharomyces cerevisiae strain MBG5227
  • a derivative thereof e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase
  • a fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae MBG5227.
  • a method of producing a fermentation product from a cellulosic-containing and/or starch-containing material comprising:
  • step (b) fermenting the saccharified material of step (a) with a fermenting organism under suitable conditions to produce the fermentation product; wherein the fermenting organism is a strain of Saccharomyces cerevisiae deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no. NRRL Y- 67971 (Saccharomyces cerevisiae strain MBG5307), or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase) or a fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae MBG5307.
  • NRRL Agricultural Research Service Patent Culture Collection
  • a method of producing a fermentation product from a cellulosic-containing and/or starch-containing material comprising:
  • step (b) fermenting the saccharified material of step (a) with a fermenting organism under suitable conditions to produce the fermentation product; wherein the fermenting organism is a strain of Saccharomyces cerevisiae deposited under the Budapest Treaty at the Agricultural Research Service Patent Culture Collection (NRRL) having deposit accession no. NRRL Y- 68202 (Saccharomyces cerevisiae strain MBG5318), or a derivative thereof (e.g., expressing a heterologous polypeptide such as a glucoamylase and/or alpha-amylase) or a fermenting organism having properties that are about the same as that of Saccharomyces cerevisiae MBG5318.
  • NRRL Agricultural Research Service Patent Culture Collection
  • Paragraph [5] The method of paragraphs [1]-[4], comprising recovering the fermentation product from the fermentation.
  • Paragraph [6] The method of paragraph [5], wherein recovering the fermentation product from the fermentation comprises distillation.
  • Paragraph [7] The method of any one of paragraphs [1]-[6], wherein fermentation and saccharification are performed simultaneously in a simultaneous saccharification and fermentation (SSF).
  • SSF simultaneous saccharification and fermentation
  • Paragraph [8] The method of any one of paragraphs [1]-[6], wherein fermentation and saccharification are performed sequentially (SHF).
  • Paragraph [9] The method of any one of paragraphs [1 ]-[8], wherein the fermentation product is ethanol.
  • step (a) comprises contacting the starch-containing and/or cellulosic-containing material with an enzyme composition.
  • step (a) comprises saccharifying a starch-containing material.
  • step (a) comprises i) liquefying a starch-containing material at a temperature above the initial gelatinization temperature using an alpha-amylase; and ii) saccharifying using a glucoamylase.
  • Paragraph [13] The process of any of paragraphs [1]-[12], wherein a protease is added in saccharification or fermentation or SSF.
  • Paragraph [14] The process of any of paragraphs [1]-[13], further comprises, prior to the liquefaction step i), the steps of: x) reducing the particle size of the starch-containing material, preferably by dry milling; y) forming a slurry comprising the starch-containing material and water.
  • Paragraph [15] The process of any of paragraphs [1]-[14], wherein at least 50%, e.g., at least 70%, at least 80%, at least 90% of the starch-containing material fits through a sieve with # 6 screen.
  • Paragraph [16] The process of any of paragraphs [1]-[15], wherein the pH in liquefaction is between 4-7, such as pH 4.5-6.5, such as pH 5.0-6.5, such as pH 5.0-6.0, such as pH 5.2-6.2, such as about 5.2, such as about 5.4, such as about 5.6, such as about 5.8.
  • Paragraph [17] The process of any of paragraphs [1]-[16], wherein the temperature in liquefaction is in the range of 70-100°C, such as 75-95°C, 75-90°C, 80-90°C, or 82-88°C, such as about 85°C.
  • Paragraph [18] The process of any of paragraphs [1]-[17], wherein a jet-cooking step is carried out prior to liquefaction.
  • Paragraph [20] The process of any of paragraphs [1]-[19], wherein saccharification is carried out at a temperature from 20-75°C, e.g., from 40-70°C, such as about 60°C, and at a pH between 4 and 5.
  • Paragraph [21] The process of any of paragraphs [1]-[20], wherein fermentation or simultaneous saccharification and fermentation (SSF) is carried out carried out at a temperature from 25°C to 40°C, such as from 28°C to 35°C, such as from 30°C to 34°C, or about 32°C. In one embodiment, fermentation is ongoing for 6 to 120 hours, in particular 24 to 96 hours.
  • SSF simultaneous saccharification and fermentation
  • Paragraph [23] The process of any of paragraphs [1]-[23], wherein the starch-containing material is derived from corn, wheat, barley, rye, milo, sago, cassava, manioc, tapioca, sorghum, oats, rice or potatoes.
  • step (a) comprises saccharifying a cellulosic-containing material.
  • Paragraph [25] The method of paragraph [24], wherein the cellulosic-containing material is p retreated.
  • Paragraph [26] The method of any of paragraphs [24] or [25], wherein the cellulosic- containing material comprises bagasse.
  • step (a) comprises contacting the cellulosic-containing material with an enzyme composition
  • the enzyme composition comprises one or more enzymes selected from a cellulase, an AA9 polypeptide, a hemicellulase, a CIP, an esterase, an expansin, a ligninolytic enzyme, an oxidoreductase, a pectinase, a protease, and a swollenin.
  • Paragraph [28] The method of paragraph [27], wherein the cellulase is one or more enzymes selected from an endoglucanase, a cellobiohydrolase, and a beta-glucosidase.
  • the hemicellulase is one or more enzymes selected a xylanase, an acetylxylan esterase, a feruloyl esterase, an arabinofuranosidase, a xylosidase, and a glucuronidase.
  • Paragraph [30] The method of any one of paragraphs [1 ]-[29], wherein the method results in at least 0.25% (e.g., 0.5%, 0.75%, 1.0%, 1.25%, 1.5%, 1.75%, 2%, 3% or 5%) yield of fermentation product.
  • Paragraph [31] The method of any one of paragraphs [1]-[30], wherein fermentation is conducted under low oxygen (e.g., anaerobic) conditions.
  • low oxygen e.g., anaerobic
  • Paragraph [32] The method of any of paragraphs [1]-[31], wherein fermenting organism has one or more of the following properties: increased ethanol yield compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions; reduced acetaldehyde production compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions; increased temperature tolerance compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No.
  • Paragraph [33] The process of any of paragraphs [1 ]-[32], wherein the fermenting organism provides an ethanol yield boost over Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) of more than 0.5%, e.g., more than 1.0%, more than 2.0%, more than 2.5%, such as about 2.9%, such as between 0.5 and 5%, such as between 1-3%, under the same process conditins, e.g., conditions as described herein.
  • Saccharomyces cerevisiae strain Ethanol Red® deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia
  • Paragraph [34] The process of any of paragraphs [1 ]-[33], wherein the fermenting organism reduces acetaldehyde production more than 10%, e.g., more than 20%, more than 30%, more than 40%, more than 45%, such as 5-60%, such as 30-50%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions, e.g., process conditions described herein.
  • Paragraph [35] The process of any of paragraphs [1 ]-[34], wherein the fermenting organism increases temperature tolerance compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions, e.g., process conditions described herein.
  • Paragraph [36] The process of any of paragraphs [1 ]-[35], wherein the fermenting organism reduces maltose (DP2) production by more than 3%, e.g., more than 4%, more than 5%, more than 6%, more than 7%, such as 2-15%, such as 5-10%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions, e.g., conditions described herein.
  • DP2 maltose
  • Paragraph [37] The process of any of paragraphs [1 ]-[36], wherein the fermenting organism reduces glycerol production by more than 3%, e.g., more than 4%, more than 5%, more than 6%, more than 7%, such as 2-15%, such as 5-10%, compared to Saccharomyces cerevisiae strain Ethanol Red® (deposited under Accession No. V14/007039 at National Measurement Institute, Victoria, Australia) under the same process conditions, e.g., conditions described herein.
  • a method of producing a derivative of Saccharomyces cerevisiae strain MBG5225 (deposited under Accession No. NRRL Y-68199 at the Agricultural Research Service Patent Culture Collection (NRRL)), comprising: a. culturing a first yeast strain with a second yeast strain, wherein the second yeast strain is Saccharomyces cerevisiae strain MBG5225 or a derivative thereof, under conditions which permit combining of DNA between the first yeast strain and the second yeast strain; and b. isolating hybrid strains; and c. optionally repeating steps (a) and (b) using a hybrid strain isolated in step (b) as the first yeast strain and/or the second yeast strain.
  • NRRL Agricultural Research Service Patent Culture Collection
  • a method of producing a derivative of Saccharomyces cerevisiae strain MBG5227 (deposited under Accession No. NRRL Y-68200 at the Agricultural Research Service Patent Culture Collection (NRRL)), comprising: a. culturing a first yeast strain with a second yeast strain, wherein the second yeast strain is Saccharomyces cerevisiae strain MBG5227 or a derivative thereof, under conditions which permit combining of DNA between the first yeast strain and the second yeast strain; and b. isolating hybrid strains; and c. optionally repeating steps (a) and (b) using a hybrid strain isolated in step (b) as the first yeast strain and/or the second yeast strain.
  • NRRL Agricultural Research Service Patent Culture Collection
  • a method of producing a derivative of Saccharomyces cerevisiae strain MBG5307 (deposited under Accession No. NRRL Y-68201 at the Agricultural Research Service Patent Culture Collection (NRRL)), comprising: a. culturing a first yeast strain with a second yeast strain, wherein the second yeast strain is Saccharomyces cerevisiae strain MBG5307 or a derivative thereof, under conditions which permit combining of DNA between the first yeast strain and the second yeast strain; and b. isolating hybrid strains; and c. optionally repeating steps (a) and (b) using a hybrid strain isolated in step (b) as the first yeast strain and/or the second yeast strain.
  • NRRL Agricultural Research Service Patent Culture Collection
  • a method of producing a derivative of Saccharomyces cerevisiae strain MBG5318 (deposited under Accession No. NRRL Y-68202 at the Agricultural Research Service Patent Culture Collection (NRRL)), comprising: a. culturing a first yeast strain with a second yeast strain, wherein the second yeast strain is Saccharomyces cerevisiae strain MBG5318 or a derivative thereof, under conditions which permit combining of DNA between the first yeast strain and the second yeast strain; and b. isolating hybrid strains; and c. optionally repeating steps (a) and (b) using a hybrid strain isolated in step (b) as the first yeast strain and/or the second yeast strain.
  • NRRL Agricultural Research Service Patent Culture Collection
  • a second yeast strain wherein the second yeast strain is Saccharomyces cerevisiae strain MBG5225 or a derivative thereof;
  • step (c) comprises screening or selecting for a hybrid strain which exhibits one or more defining characteristic of Saccharomyces cerevisiae strain MBG5225.
  • step (d) repeating steps (a) and (b) with the screened or selected strain from step (c) as the first and/or second strain, until a derivative is obtained which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5225.
  • a second yeast strain wherein the second yeast strain is Saccharomyces cerevisiae strain MBG5227 or a derivative thereof;
  • step (c) comprises screening or selecting for a hybrid strain which exhibits one or more defining characteristic of Saccharomyces cerevisiae strain MBG5227.
  • step (d) repeating steps (a) and (b) with the screened or selected strain from step (c) as the first and/or second strain, until a derivative is obtained which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5227.
  • a second yeast strain wherein the second yeast strain is Saccharomyces cerevisiae strain MBG5307 or a derivative thereof;
  • step (c) comprises screening or selecting for a hybrid strain which exhibits one or more defining characteristic of Saccharomyces cerevisiae strain MBG5307.
  • step (d) repeating steps (a) and (b) with the screened or selected strain from step (c) as the first and/or second strain, until a derivative is obtained which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5307.
  • a second yeast strain wherein the second yeast strain is Saccharomyces cerevisiae strain MBG5318 or a derivative thereof;
  • step (c) comprises screening or selecting for a hybrid strain which exhibits one or more defining characteristic of Saccharomyces cerevisiae strain MBG5318.
  • step (d) repeating steps (a) and (b) with the screened or selected strain from step (c) as the first and/or second strain, until a derivative is obtained which exhibits the defining characteristics of Saccharomyces cerevisiae strain MBG5318.
  • Saccharomyces cerevisiae strain MBG5225 (or a derivative of Saccharomyces cerevisiae strain MBG5225) with one or more expression vectors (e.g., one or more expression vectors encoding a glucoamylase and/or an alpha-amylase); and
  • Saccharomyces cerevisiae strain MBG5227 (or a derivative of Saccharomyces cerevisiae strain MBG5227) with one or more expression vectors (e.g., one or more expression vectors encoding a glucoamylase and/or an alpha-amylase); and
  • Saccharomyces cerevisiae strain MBG5318 (or a derivative of Saccharomyces cerevisiae strain MBG5318) with one or more expression vectors (e.g., one or more expression vectors encoding a glucoamylase and/or an alpha-amylase); and
  • Paragraph [68] A method of producing ethanol, comprising incubating a Saccharomyces cerevisiae strain of any of paragraphs [38]-[42] and [67] with a substrate comprising a fermentable sugar under conditions which permit fermentation of the fermentable sugar to produce ethanol.
  • Saccharomyces cerevisiae strain MBG5225 deposited under Accession No. NRRL Y-68199 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA) in the production of a Saccharomyces strain having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5225 or which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5225.
  • Saccharomyces cerevisiae strain MBG5227 deposited under Accession No. NRRL Y-68200 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA) in the production of a Saccharomyces strain having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5227 or which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5227.
  • Saccharomyces cerevisiae strain MBG5307 deposited under Accession No. NRRL Y-68201 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA) in the production of a Saccharomyces strain having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5307 or which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5307.
  • Saccharomyces cerevisiae strain MBG5318 deposited under Accession No. NRRL Y-68202 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA) in the production of a Saccharomyces strain having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5318 or which exhibits one or more defining characteristics of Saccharomyces cerevisiae strain MBG5318.
  • NRRL Y-68202 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA) or a strain having properties that are about the same as that of Saccharomyces cerevisiae strain MBG5318 or a derivative thereof in a method according to any of paragraphs [4], and [5]-[37],
  • Paragraph [77] A composition comprising a Saccharomyces cerevisiae strain of any of paragraphs [38]-[42] and [67], and one or more naturally occurring and/or non-naturally occurring components.
  • Paragraph [78] The composition of paragraph [77], wherein the components are selected from the group consisting of: surfactants, emulsifiers, gums, swelling agents, and antioxidants.
  • Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5225 (deposited under Accession No. NRRL Y-68199 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA).
  • Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5227 (deposited under Accession No. NRRL Y-68200 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA).
  • Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5307 (deposited under Accession No. NRRL Y Y-68201 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA).
  • Saccharomyces cerevisiae strain is Saccharomyces cerevisiae strain MBG5318 (deposited under Accession No. NRRL Y-68202 at the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 University Street, Peoria, IL, USA).
  • Paragraph [83] The composition of any of paragraphs [77]-[82], wherein the Saccharomyces cerevisiae strain is in a viable form, in particular in dry, cream or compressed form.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des procédés de production d'éthanol comprenant la saccharification d'un matériau cellulosique ou contenant de l'amidon et la fermentation du matériau saccharifié avec un micro-organisme de fermentation pour produire de l'éthanol. L'organisme de fermentation est la souche MBG5225 de Saccharomyces cerevisiae (déposée sous le No Y-68199 dans la Collection de Culture de Service de recherche agricole (NRRL), Illinois 61604 USA), la souche MBG5227 de Saccharomyces cerevisiae (déposée sous le No Y-68200 dans la Collection de Culture de Service de recherche agricole (NRRL), Illinois 61604 USA), la souche MBG5307 de Saccharomyces cerevisiae (déposée sous le No Y-68201 dans la Collection de Culture de Service de recherche agricole (NRRL), Illinois 61604 USA), la souche MBG5318 de Saccharomyces cerevisiae (déposée sous le No Y-68202 dans la Collection de Culture de Service de recherche agricole (NRRL), Illinois 61604 USA) ou un organisme de fermentation qui a des propriétés qui sont identiques ou quasiment identiques à celles de Saccharomyces cerevisiae MBG5225, MBG5227, MBG5307 ou MBG5318.
PCT/US2023/074919 2022-09-23 2023-09-22 Organisme de fermentation améliorée de production d'éthanol WO2024064901A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263409501P 2022-09-23 2022-09-23
US63/409,501 2022-09-23

Publications (2)

Publication Number Publication Date
WO2024064901A2 true WO2024064901A2 (fr) 2024-03-28
WO2024064901A3 WO2024064901A3 (fr) 2024-05-16

Family

ID=88585162

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/074919 WO2024064901A2 (fr) 2022-09-23 2023-09-22 Organisme de fermentation améliorée de production d'éthanol

Country Status (1)

Country Link
WO (1) WO2024064901A2 (fr)

Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021785A1 (fr) 1993-03-10 1994-09-29 Novo Nordisk A/S Enzymes derivees d'aspergillus aculeatus presentant une activite de xylanase
US5646025A (en) 1995-05-05 1997-07-08 Novo Nordisk A/S Scytalidium catalase gene
US20020164730A1 (en) 2000-02-24 2002-11-07 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas (C.I.E.M.A.T.) Procedure for the production of ethanol from lignocellulosic biomass using a new heat-tolerant yeast
WO2002095014A2 (fr) 2001-05-18 2002-11-28 Novozymes A/S Polypeptides presentant une activite de cellobiase et polynucleotides codant pour de tels polypeptides
WO2005047499A1 (fr) 2003-10-28 2005-05-26 Novozymes Inc. Polypeptides presentant une activite beta-glucosidase et polynucleotides codant pour ceux-ci
WO2005074656A2 (fr) 2004-02-06 2005-08-18 Novozymes, Inc. Polypeptides presentant une amelioration de l'activite cellulolytique et polynucleotides codant pour de tels polypeptides
WO2006032282A1 (fr) 2004-09-24 2006-03-30 Cambi Bioethanol Aps Procede de traitement de biomasse et de dechets organiques pour la generation de produits a base biologique desires
WO2006078256A2 (fr) 2004-02-12 2006-07-27 Novozymes, Inc. Polypeptides presentant une activite xylanase et polynucleotides codant pour ceux-ci
WO2006110899A2 (fr) 2005-04-12 2006-10-19 E. I. Du Pont De Nemours And Company Procede d'integration d'autres charges d'alimentation dans le traitement d'une biomasse et utilisation du procede
EP1724336A1 (fr) 2005-05-19 2006-11-22 Paul Dr. Fricko Procédé pour améliorer la qualité de séchage et de produit de microorganismes
WO2008057637A2 (fr) 2006-07-21 2008-05-15 Novozymes, Inc. Procédés d'augmentation de la sécrétion de polypeptides ayant une activité biologique
WO2011041397A1 (fr) 2009-09-29 2011-04-07 Novozymes, Inc. Polypeptides présentant une activité favorisant l'activité cellulolytique et polynucléotides codant pour ceux-ci
WO2011057140A1 (fr) 2009-11-06 2011-05-12 Novozymes, Inc. Compositions pour la saccharification des matières cellulosiques
WO2011153516A2 (fr) 2010-06-03 2011-12-08 Mascoma Corporation Levure à expression d'enzymes saccharolytiques pour la transformation biologique consolidée au moyen d'amidon et de cellulose
WO2012021401A1 (fr) 2010-08-12 2012-02-16 Novozymes, Inc. Compositions comprenant un polypeptide ayant une activité améliorant la cellulolyse et un composé bicyclique, et utilisations correspondantes
WO2012044915A2 (fr) 2010-10-01 2012-04-05 Novozymes, Inc. Variants de bêta-glucosidase et polynucléotides les codant
WO2012103293A1 (fr) 2011-01-26 2012-08-02 Novozymes A/S Polypeptides ayant une activité cellobiohydrolase et polynucléotides codant pour ceux-ci
WO2012103288A1 (fr) 2011-01-26 2012-08-02 Novozymes A/S Polypeptides possédant une activité de cellobiohydrolase et polynucléotides les codant
US8257959B2 (en) 2004-06-08 2012-09-04 Microbiogen Pty Ltd Non-recombinant Saccharomyces strains that grow on xylose
WO2012130120A1 (fr) 2011-03-25 2012-10-04 Novozymes A/S Procédé de dégradation ou de conversion d'une matière cellulosique
WO2013019827A2 (fr) 2011-08-04 2013-02-07 Novozymes A/S Polypeptides ayant une activité xylanase et polynucléotides codant pour ceux-ci
WO2013028928A1 (fr) 2011-08-24 2013-02-28 Novozymes, Inc. Compositions d'enzymes cellulolytiques et leurs utilisations
WO2013028912A2 (fr) 2011-08-24 2013-02-28 Novozymes, Inc. Procédés de production de multiples polypeptides recombinants dans une cellule hôte fongique filamenteuse
US20150125925A1 (en) 2013-11-05 2015-05-07 The Procter & Gamble Company Compositions and methods comprising serine protease variants
WO2016045569A1 (fr) 2014-09-23 2016-03-31 Novozymes A/S Procédés de production d'éthanol et organismes de fermentation
WO2016087237A1 (fr) 2014-12-02 2016-06-09 Mahle International Gmbh Procédé de fabrication d'un noyau de coulée perdu, noyau de coulée perdu et piston à conduit de refroidissement fabriqué à l'aide d'un tel noyau de coulée
WO2018222990A1 (fr) 2017-06-02 2018-12-06 Novozymes A/S Levure améliorée pour la production d'éthanol
WO2019161227A1 (fr) 2018-02-15 2019-08-22 Novozymes A/S Levure améliorée pour la production d'éthanol
WO2020023411A1 (fr) 2018-07-25 2020-01-30 Novozymes A/S Levure exprimant une enzyme pour la production d'éthanol

Patent Citations (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021785A1 (fr) 1993-03-10 1994-09-29 Novo Nordisk A/S Enzymes derivees d'aspergillus aculeatus presentant une activite de xylanase
US5646025A (en) 1995-05-05 1997-07-08 Novo Nordisk A/S Scytalidium catalase gene
US20020164730A1 (en) 2000-02-24 2002-11-07 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas (C.I.E.M.A.T.) Procedure for the production of ethanol from lignocellulosic biomass using a new heat-tolerant yeast
WO2002095014A2 (fr) 2001-05-18 2002-11-28 Novozymes A/S Polypeptides presentant une activite de cellobiase et polynucleotides codant pour de tels polypeptides
WO2005047499A1 (fr) 2003-10-28 2005-05-26 Novozymes Inc. Polypeptides presentant une activite beta-glucosidase et polynucleotides codant pour ceux-ci
WO2005074656A2 (fr) 2004-02-06 2005-08-18 Novozymes, Inc. Polypeptides presentant une amelioration de l'activite cellulolytique et polynucleotides codant pour de tels polypeptides
WO2006078256A2 (fr) 2004-02-12 2006-07-27 Novozymes, Inc. Polypeptides presentant une activite xylanase et polynucleotides codant pour ceux-ci
US8257959B2 (en) 2004-06-08 2012-09-04 Microbiogen Pty Ltd Non-recombinant Saccharomyces strains that grow on xylose
WO2006032282A1 (fr) 2004-09-24 2006-03-30 Cambi Bioethanol Aps Procede de traitement de biomasse et de dechets organiques pour la generation de produits a base biologique desires
WO2006110899A2 (fr) 2005-04-12 2006-10-19 E. I. Du Pont De Nemours And Company Procede d'integration d'autres charges d'alimentation dans le traitement d'une biomasse et utilisation du procede
WO2006110891A2 (fr) 2005-04-12 2006-10-19 E. I. Du Pont De Nemours And Company Obtention de produit chimique cible par traitement de biomasse
WO2006110900A2 (fr) 2005-04-12 2006-10-19 E. I. Du Pont De Nemours And Company Traitement de biomasse en vue d'obtenir de l'ethanol
WO2006110901A2 (fr) 2005-04-12 2006-10-19 E. I. Du Pont De Nemours And Company Traitement de biomasse en vue d'obtenir des sucres fermentescibles
EP1724336A1 (fr) 2005-05-19 2006-11-22 Paul Dr. Fricko Procédé pour améliorer la qualité de séchage et de produit de microorganismes
WO2008057637A2 (fr) 2006-07-21 2008-05-15 Novozymes, Inc. Procédés d'augmentation de la sécrétion de polypeptides ayant une activité biologique
WO2011041397A1 (fr) 2009-09-29 2011-04-07 Novozymes, Inc. Polypeptides présentant une activité favorisant l'activité cellulolytique et polynucléotides codant pour ceux-ci
WO2011057140A1 (fr) 2009-11-06 2011-05-12 Novozymes, Inc. Compositions pour la saccharification des matières cellulosiques
WO2011153516A2 (fr) 2010-06-03 2011-12-08 Mascoma Corporation Levure à expression d'enzymes saccharolytiques pour la transformation biologique consolidée au moyen d'amidon et de cellulose
WO2012021401A1 (fr) 2010-08-12 2012-02-16 Novozymes, Inc. Compositions comprenant un polypeptide ayant une activité améliorant la cellulolyse et un composé bicyclique, et utilisations correspondantes
WO2012044915A2 (fr) 2010-10-01 2012-04-05 Novozymes, Inc. Variants de bêta-glucosidase et polynucléotides les codant
WO2012103293A1 (fr) 2011-01-26 2012-08-02 Novozymes A/S Polypeptides ayant une activité cellobiohydrolase et polynucléotides codant pour ceux-ci
WO2012103288A1 (fr) 2011-01-26 2012-08-02 Novozymes A/S Polypeptides possédant une activité de cellobiohydrolase et polynucléotides les codant
WO2012130120A1 (fr) 2011-03-25 2012-10-04 Novozymes A/S Procédé de dégradation ou de conversion d'une matière cellulosique
WO2013019827A2 (fr) 2011-08-04 2013-02-07 Novozymes A/S Polypeptides ayant une activité xylanase et polynucléotides codant pour ceux-ci
WO2013028928A1 (fr) 2011-08-24 2013-02-28 Novozymes, Inc. Compositions d'enzymes cellulolytiques et leurs utilisations
WO2013028912A2 (fr) 2011-08-24 2013-02-28 Novozymes, Inc. Procédés de production de multiples polypeptides recombinants dans une cellule hôte fongique filamenteuse
US20150125925A1 (en) 2013-11-05 2015-05-07 The Procter & Gamble Company Compositions and methods comprising serine protease variants
WO2016045569A1 (fr) 2014-09-23 2016-03-31 Novozymes A/S Procédés de production d'éthanol et organismes de fermentation
WO2016087237A1 (fr) 2014-12-02 2016-06-09 Mahle International Gmbh Procédé de fabrication d'un noyau de coulée perdu, noyau de coulée perdu et piston à conduit de refroidissement fabriqué à l'aide d'un tel noyau de coulée
WO2018222990A1 (fr) 2017-06-02 2018-12-06 Novozymes A/S Levure améliorée pour la production d'éthanol
WO2019161227A1 (fr) 2018-02-15 2019-08-22 Novozymes A/S Levure améliorée pour la production d'éthanol
WO2020023411A1 (fr) 2018-07-25 2020-01-30 Novozymes A/S Levure exprimant une enzyme pour la production d'éthanol

Non-Patent Citations (76)

* Cited by examiner, † Cited by third party
Title
"Eur. J. Biochem.", vol. 223, 1994, ACADEMIC PRESS, article "The EC number refers to Enzyme Nomenclature 1992 from NC-IUBMB", pages: 1 - 5
ALIZADEH ET AL., APPL. BIOCHEM. BIOTECHNOL, vol. 121, 2005, pages 1133 - 1141
BALLESTEROS ET AL., APPL. BIOCHEM. BIOTECHNOL, vol. 129-132, 2006, pages 496 - 508
CASTILHOS CORAZZA ET AL., ACTA SCIENTIARUM. TECHNOLOGY, vol. 25, 2003, pages 33 - 38
CHANDRA ET AL., ADV. BIOCHEM. ENGIN./BIOTECHNOL, vol. 108, 2007, pages 41 - 65
CHENLEE, APPL. BIOCHEM. BIOTECHNOL, vol. 63-65, 1997, pages 435 - 448
CHUNDAWAT ET AL., BIOTECHNOL. BIOENG, vol. 96, 2007, pages 219 - 231
DUFFMURRAY, BIORESOURCE TECHNOLOGY, vol. 855, 1996, pages 1 - 33
EUR. J. BIOCHEM, vol. 232, 1995, pages 1 - 6
EUR. J. BIOCHEM., vol. 237, 1996, pages 1 - 5
EUR. J. BIOCHEM., vol. 250, 1997, pages 1 - 6
EUR. J. BIOCHEM., vol. 264, 1999, pages 610 - 650
EZEJI ET AL., WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603
GALBEZACCHI, APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 618 - 628
GHOSE, PURE AND APPL. CHEM, vol. 59, 1987, pages 257 - 268
GHOSE, PURE APPL. CHEM, vol. 59, 1987, pages 257 - 68
GHOSEBISARIA, PURE & APPL. CHEM, vol. 59, 1987, pages 1739 - 1752
GHOSHSINGH, ADV. APPL. MICROBIOL, vol. 39, 1993, pages 295 - 333
GOLLAPALLI ET AL., APPL. BIOCHEM. BIOTECHNOL, vol. 98, 2002, pages 23 - 35
GONG, C. SCAO, N. J., DU, JTSAO, G. T: "Advances in Biochemical Engineering/Biotechnology", vol. 65, 1999, SPRINGER-VERLAG BERLIN HEIDELBERG, article "Recent Progress in Bioconversion of Lignocellulosics", pages: 207 - 241
GORINSTEINLII, STARCH/STARKE, vol. 44, no. 12, 1992, pages 461 - 466
GUNASEELAN, BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114
GUSAKOVSINITSYN, ENZ. MICROB. TECHNOL, vol. 7, 1985, pages 346 - 352
HENDRIKSZEEMAN, BIORESOURCE TECHNOLOGY, vol. 100, 2009, pages 10 - 18
HENRISSAT, BIOCHEM. J, vol. 280, 1991, pages 309 - 316
HENRISSATBAIROCH, BIOCHEM. J, vol. 316, 1996, pages 695 - 696
INGE-VECHYMOV ET AL., GENETIKA, vol. 22, 1986, pages 2625 - 2636
KARIMAKI ET AL., PROTEIN ENG DES SEL, vol. 17, no. 12, pages 861 - 869
KATAOKA ET AL., WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 1371 - 1377
KURTZMAN, FEMS YEAST RESEARCH, vol. 4, 2003, pages 233 - 245
LAWRENCE C.W., METHODS IN ENZYMOLOGY, vol. 194, 1991, pages 273 - 281
LEE ET AL., ADV. BIOCHEM. ENG. BIOTECHNOL, vol. 65, 1999, pages 93 - 115
LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279
LIN ET AL., BIOTECHNOL. BIOENG, vol. 90, 2005, pages 775 - 779
LIN ET AL., STRUCTURE, vol. 20, 2012, pages 1051 - 1061
LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24, 25, 1990, pages 695 - 719
MARTIN ET AL., J. CHEM. TECHNOL. BIOTECHNOL, vol. 81, 2006, pages 1669 - 1677
MCMILLAN, J. D: "Enzymatic Conversion of Biomass for Fuels Production", 1994, AMERICAN CHEMICAL SOCIETY, article "Pretreating lignocellulosic biomass: a review"
NEEDLEMANWUNSCH, J. MOL. BIOL, vol. 48, 1970, pages 443 - 453
NIGAMSINGH, PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124
OLSSONHAHN-HAGERDAL, ENZ. MICROB. TECH, vol. 18, 1996, pages 312 - 331
PALONEN ET AL., APPL. BIOCHEM. BIOTECHNOL, vol. 113-116, 2004, pages 509 - 523
PAN ET AL., BIOTECHNOL. BIOENG, vol. 94, 2006, pages 851 - 861
PHILIPPIDIS, G. P: "Handbook on Bioethanol: Production and Utilization", 1996, TAYLOR & FRANCIS, article "Cellulose bioconversion technology", pages: 179 - 212
PHILLIPS ET AL., ACS CHEM. BIOL., vol. 6, 2011, pages 1399 - 1406
QUINLAN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 208, 2011, pages 15079 - 15084
R.R. FOWEL: "The Yeasts", vol. 1, 1969, ACADEMIC PRESS, article "Sporulation and Hybridisation of yeast"
RICE ET AL.: "EMBOSS: The European Molecular Biology Open Software Suite", TRENDS GENET, vol. 16, 2000, pages 276 - 277, XP004200114, DOI: 10.1016/S0168-9525(00)02024-2
RICHARD ET AL., FEBS MICROBIOL. LETTERS, vol. 190, 2000, pages 39 - 43
RICHARD1999 ET AL., FEBS LETTERS, vol. 457, pages 135 - 138
RICHARDMARGARITIS, BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515
RYULEE, BIOTECHNOL. BIOENG, vol. 25, 1983, pages 53 - 65
SASSNER ET AL., ENZYME MICROB. TECHNOL, vol. 39, 2006, pages 756 - 762
SCHELL ET AL., APPL. BIOCHEM. BIOTECHNOL, vol. 105-108, 2003, pages 69 - 85
SCHELL ET AL., BIORESOURCE TECHNOLOGY, vol. 91, 2004, pages 179 - 188
SCHMIDTTHOMSEN, BIORESOURCE TECHNOLOGY, vol. 64, 1998, pages 139 - 151
SHALLOMSHOHAM, CURRENT OPINION IN MICROBIOLOGY, vol. 6, no. 3, 2003, pages 219 - 228
SHEEHANHIMMEL, BIOTECHNOL. PROG, vol. 15, 1999, pages 817 - 827
SIEZEN ET AL., PROTEIN ENGNG, vol. 4, 1991, pages 719 - 737
SIEZEN ET AL., PROTEIN SCIENCE, vol. 6, 1997, pages 501 - 523
SILVEIRAJONAS, APPL. MICROBIOL. BIOTECHNOL, vol. 59, 2002, pages 400 - 408
TAHERZADEHKARIMI, INT. J. MOL. SCI, vol. 9, 2008, pages 1621 - 1651
TEERI ET AL., BIOCHEM. SOC. TRANS, vol. 26, 1998, pages 173 - 178
TEERI, TRENDS IN BIOTECHNOLOGY, vol. 15, 1997, pages 160 - 167
TEYMOURI ET AL., BIORESOURCE TECHNOLOGY, vol. 96, 2005, pages 2014 - 2018
TOMME ET AL., EUR. J. BIOCHEM, vol. 170, 1988, pages 575 - 581
VALLANDERERIKSSON, ADV. BIOCHEM. ENG./BIOTECHNOL, vol. 42, 1990, pages 63 - 95
VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156
VAN TILBEURGHCLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288
VARGA ET AL., BIOTECHNOL. BIOENG, vol. 88, 2004, pages 567 - 574
VENTURI ET AL., J. BASIC MICROBIOL, vol. 42, 2002, pages 55 - 66
VERHOEVEN, SCI REP, vol. 7, 2017, pages 46155
WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16
YANGWYMAN, BIOFUELS BIOPRODUCTS AND BIOREFINING-BIOFPR, vol. 2, 2008, pages 26 - 40
ZHANG ET AL., BIOTECHNOLOGY ADVANCES, vol. 24, 2006, pages 452 - 481
ZHANGHENZEL, PROTEIN SCIENCE, vol. 13, 2004, pages 2819 - 2824

Also Published As

Publication number Publication date
WO2024064901A3 (fr) 2024-05-16

Similar Documents

Publication Publication Date Title
US11866751B2 (en) Yeast expressing a heterologous alpha-amylase for ethanol production
US20220348967A1 (en) Microorganisms With Improved Nitrogen Utilization For Ethanol Production
CA3064042A1 (fr) Levure amelioree pour la production d'ethanol
EP4009807A1 (fr) Mélanges d'enzymes et procédés de production d'un ingrédient d'alimentation animale à haute teneur en protéines à partir d'un sous-produit de type résidu de distillation entier
EP4010469A1 (fr) Protéines de fusion pour une expression enzymatique améliorée
US20230193216A1 (en) Engineered microorganism for improved pentose fermentation
US20230002794A1 (en) Microorganism for improved pentose fermentation
US20210381009A1 (en) Enzyme-Expressing Yeast For Ethanol Production
WO2022261003A1 (fr) Micro-organisme génétiquement modifié pour une fermentation d'éthanol améliorée
US20230183639A1 (en) Improved microorganisms for arabinose fermentation
US20220251609A1 (en) Microorganisms with improved nitrogen transport for ethanol production
US20230332188A1 (en) Improved fermenting organism for ethanol production
WO2024064901A2 (fr) Organisme de fermentation améliorée de production d'éthanol
CN116724117A (zh) 用于乙醇生产的改进发酵生物